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Abstract 
 
This study was carried out in clusters of villages that represent an endemic focus of 
visceral leishmaniasis (VL). These villages were located in Gedaref state, eastern 
Sudan. For diagnostic purposes polymerase chain reaction (PCR) was performed 
successfully, directly from clinical samples spotted on filter papers with no prior 
cultivation from 100 patients suspected of having kala-azar or post kala-azar dermal 
leishmaniasis. Mainly the ribosomal internal transcribed spacer (ITS1 & ITS2) were 
targeted in PCR because this region is more variable and allows clear species 
identification and also strain differences could be expected by further analysis of these 
PCR products. PCR was found to be more sensitive compared to the gold standard 
microscopic method. Four PCR based approaches were used to analyse diversity 
within Sudanese isolates of Leishmania donovani. Methods compared were 
fingerprinting with single non-specific primers, restriction analysis of the amplified 
ITS locus (RFLP), single-stranded conformation polymorphism (SSCP) of the ITS 
region, major surface protease (gp63) gene, anonymous DNA fragments and 
sequencing of these targeted regions. When PCR fingerprinting and restriction analysis 
of ITS region were applied, highly similar fragment patterns were observed for all 
strains of L. donovani studied. The ITS1 locus gave 12 different SSCP profiles among 
the 86 Sudanese isolates, where as the ITS2 locus was highly conserved among the 86 
samples with the exception of 1 isolate. Strains of L. donovani derived from other 
geographical areas were found to have different ITS2 patterns. The gp63 locus gave 3 
polymorphic patterns among 31 Sudanese isolates. Concerning most of the anonymous 
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 DNA fragments namely, L510, L413, LK413, L0308 and L0114 unfortunately, we 
succeeded to get good PCR products only from DNA extracted 8 successful cultures. 
Only for the fragment L0110 we were able to get good PCR products from 31 samples 
spotted on filter papers. When these PCR products were investigated for 
polymorphisms using SSCP no differences were observed with exception of L0114 
region, which showed 2 patterns. SSCP analysis correlates well with results of DNA 
sequencing and confirmed that SSCP was able to detect genetic diversity at the level of 
a single nucleotide. SSCP had advantages over the other methods employed for 
investigating of sequence variation within the species L. donovani. There was no 
correlation between the form of clinical manifestation of the disease and the PCR 
fingerprinting, ITS-RFLP, or ITS-SSCP characteristics. This study is beneficial 
particularly in epidemiological studies based on field-work where obtaining cultures 
can be extremely difficult especially in developing countries. 
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 Zusammenfassung 
 
 
Die vorliegende Studie wurde in einer Gruppe von Dörfern im Ostsudan, Gedaref State, 
durchgeführt. Bei 100 Patienten mit der Verdachtsdiagnose Kala Azar- oder Post-Kala 
Azar-Leishmaniose war der Erregernachweis mit der PCR direkt in klinischen Proben, 
die auf Filterpapier aufgebracht worden waren, ohne vorherige Kultivierung 
erfolgreich. In dieser PCR wurden die ribosomalen, internal transcribed spacer (ITS1 
& ITS2) amplifiziert, weil sie sehr variabel sind, eine klare Speziesidentifizierung 
gestatten und bei weiterführenden Analysen der PCR-Produkte auch der Nachweis 
stammspezifischer Unterschiede erwartet werden konnte. Für die Analyse der 
Diversität von Leishmania donovani-Isolaten aus dem Sudan wurden 4 verschiedene 
PCR-basierte Methoden eingesetzt: das PCR-Fingerprinting mit unspezifischen 
Einzelprimern, die RFLP- Analyse des amplifizierten ITS-Locus, ,,single strand 
conformation polymorphism (SSCP)- Analysen der amplifizierten ITS-Region, des 
Gens, welches für die Hauptoberflächenprotease (gp63) kodiert, und anonymer DNA-
Fragmente sowie Sequenzanalysen der entsprechenden Zielregionen. Das PCR-
Fingerprinting und die Restriktionsanalyse der ITS-Region lieferten weitgehend 
übereinstimmende Fragmentmuster für alle untersuchten L.donovani-Stämme. 12 
unterschiedliche Profile wurden bei der SSCP-Analyse des ITS1-Locus für 86 Isolate 
aus dem Sudan erhalten, während der ITS2-Locus bei diesen Stämmen 
hochkonserviert war und nur ein Stamm ein unterschiedliches SSCP-Muster aufwies. L. 
Donovani -Stämme anderer geographischer Herkunft hatten unterschiedliche ITS2-
Profile in der SSCP. Für den gp63 - Locus waren 3 polymorphe SSCP-Muster bei 31 
untersuchten sudanesischen Isolaten nachweisbar. Für die meisten der anonymen 
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 DNA-Fragmente, L510, L413, LK413, L0308 UND L0114, konnten leider nur von 8 
kultivierten Stämmen gute PCR-Produkte erhalten werden. Lediglich das Fragment 
L0110 konnte erfolgreich von 31 auf Filterpapier aufgebrachten Proben direkt 
amplifiziert werden. Die Suche nach Polymorphismen mit der SSCP ergab keine 
Unterschiede in diesen anonymen DNA-Regionen, mit Ausnahme des Fragments 
L0114, das zwei verschiedene Muster aufwies. Die Ergebnisse der SSCP-Analysen 
und der DNA-Sequenzierung stimmten gut überein, wodurch bestätigt wurde, dass die 
SSCP genetische Unterschiede auf dem Niveau einzelner Basenaustausche nachweisen 
kann. Die SSCP-Technik hat Vorteile gegenüber den anderen Methoden, die für die 
Untersuchung von Sequenzvariationen innerhalb der Spezies L. donovani angewandt 
wurden. Es konnten keine Korrelationen zwischen der Form der klinischen 
Manifestation und den Ergebnissen des PCR-Fingerprinting, der ITS-RFLP- und ITS-
SSCP- Analysen festgestellt warden. Diese Studie ist von besonderem Nutzen in 
epidemiologischen Feldstudien, bei denen die Kultivierung der Erreger besonders in 
Entwicklungsländern extrem schwierig sein kann.  
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 1 Introduction 
1.1 
1.1.1 
Leishmaniasis: 
The disease: 
The Leishmaniasis is a globally widespread group of diseases caused by obligatory, 
intracellular, haemoflagellate protozoan parasites of the genus leishmania (family 
trypanosomatidae). The disease manifests itself in a variety of clinical forms, ranging 
from the self-healing cutaneous lesions to the more serious, potentially fatal 
visceralizing form, and includes the metastasising muco-cutaneous form, and the post 
kala-azar dermal leishmaniasis. 
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Leishmaniasis forced itself upon medical attention as an increasingly significant 
problem over the last decade. Because of its importance, leishmaniasis is considered as 
one of the 6 diseases selected by WHO for its special programme for research and 
training in tropical diseases (WHO, 1984). It ranks only second to malaria among 
human protozoan diseases (Chang et al., 1985). It is prevalent on 4 continents: Africa, 
Europe, Asia, Central and Latin America and is endemic in the tropical and subtropical 
regions of 88 countries (WHO, 1998). Sixteen are developed countries, 72 are 
developing countries, 13 of them are among the least developed (Desjeux, 1996). 
Overall, it has been estimated that there are 12-13 million of cases of leishmaniasis 
world-wide, over 90% of cases are found in 3 regions: Sudan/Ethiopia/Kenya; 
India/Bangladesh/Nepal and Brazil (WHO, 1991; WHO, 1996), with as many as 100 
000 deaths every year (Ashford et al., 1992). Figures of 1-1.5 million new cases of 
cutaneous leishmaniasis (CL), representing 50 to 75 percent of all new cases, and 
500,000 cases of visceral leishmaniasis (VL) per year are likely and 350 million people 
 are at risk (WHO, 1998 & 2000). This only represent the 'tip of the iceberg, since not 
all infected individuals develop a disease (Hommel, 1999). 
 
1.1.2 
1.1.2.1 
Clinial spectrum: 
Visceral leishmaniasis (VL): 
Also known in Asia as ' black fever' or 'kala-azar' is the most severe form of the 
disease, the parasite invades internal organs (spleen, liver, bone marrow) and the 
consequences are usually with an almost 100% mortality rate if left untreated. It is 
characterized by irregular fever, loss of weight, splenomegaly, hepatomegaly and/or 
lymphadenopathy and anaemia. Of the 500,000 new cases of VL, which occur 
annually, 90% are in 5 countries Bangladesh, Brazil, India, Nepal and Sudan (Desjeux, 
1996; WHO, 1996 &1998). VL is caused by L. donovani on the Indian subcontinent 
and in East Africa, by L. infantum in the Mediterranean region and by L. chagasi, 
which is closely related to or not distinguished from L. infantum (Mauricio et al., 
2000), in the New World mainly in Brazil, Peru and Paraguay (Berman, 1997).  
 
The association of VL and HIV infection clearly confirms the fact that VL is an 
opportunistic infection. HIV/Leishmania co-infections are considered to be a real 
threat, especially in southern Europe, where approximately 700 cases of co-infection 
have been reported to WHO. Now in southern Europe, VL is the most common 
opportunistic parasitic infection among HIV positive persons. Most co-infections in the 
Americas are reported from Brazil. In eastern Africa, cases of leishmania/HIV co-
infection have been reported in Ethiopia (27), Kenya (13), Malawi (1) and Sudan (3). 
The risk of overlap is increasing due to a number of factors: mass migration, civil 
unrest, resettlement programmes and promiscuity and prostitution in refugee camps. In 
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 North Africa, a few cases have been reported in Algeria, Morocco, and Tunisia and in 
western Africa 1 case in Cameroon and 1 case in Guinea Bissau (WHO, 1996). AIDS 
and VL are locked in a vicious circle of mutual reinforcement. VL accelerates the 
onset of full-blown AIDS, and shortens the life expectancy of HIV-infected people, 
while HIV spurs the spread of VL. The gridlock produce cumulative deficiency of the 
immunoresponse, as Leishmania parasites and HIV destroy the same cells (WHO, 
1998). 
 
Canine VL is regarded as both an important veterinary problem and a problem 
concerning human health, as the dog is the main reservoir of L. infantum and L. 
chagasi. An increase in both VL and canine VL cases has been reported in most 
Mediterranean countries in recent years (WHO, 1990). 
 
1.1.2.2 Post kala-azar dermal leishmaniasis (PKDL):  
It is a dermatropic form of leishmaniasis developed by part of the ex- VL patients 
(WHO, 1990), but there are cases without any previous known history of VL (El-
Hassan et al., 1992). The disease is characterized by the development of macules, 
papules and nodules, which first appear around the mouth; those which do not heal 
spontaneously become more dense and spread over the entire body (Berman, 1997). 
The interval between the end of treatment of VL and the onset of PKDL is variable: 
PKDL may appear during or directly after treatment (Zijlstra et al., 1995) to up to 2 
years post treatment (Zijlstra et al., 1991). PKDL patients may be important sources of 
infection in VL transmission (Addy & Nandy, 1992; WHO, 1990). 
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 1.1.2.3 
1.1.2.4 
1.1.2.5 
Cutaneous leishmaniasis (CL): 
It is known, as 'little sister' in some countries that the disease is so common that is part 
of the family. In the Old World is known as oriental sore. It produces skin lesions, 
sometimes as many as 200 on the face, arms and legs, causing serious disability and 
permanent scars (WHO, 1998).  In the Old World is caused by Leishmania major, 
Leishmania tropica and Leishmania aethiopica. In the New World CL is caused by L. 
mexicana and L. braziliensis complexes. Some L. infantum and L. donovani strains can 
also cause lesions. Ninety percent of all cases of CL occur in Afghanistan, Brazil, Iran, 
Peru, Saudi Arabia and Syria, with 1-1.5 million new cases reported annually world-
wide (WHO, 1996). L. major usually produces self-healing lesions, on the other hand, 
L. tropica is usually more chronic, and its most severe form, recidivans leishmaniasis, 
is very difficult to treat. In the New World, L. mexicana usually produces relatively 
benign lesions but some locations such as the ear's pinna are very difficult to treat in 
general (Desjeux, 1996). 
 
Diffuse cutaneous leishmaniasis (DCL):  
It is less common, chronic in evolution and especially difficult to treat. It produces 
lesions resembling leprosy, which do not heal spontaneously, due to deficiency of the 
immune response (Desjeux, 1996; WHO, 1998). DCL is due to L. aethiopica and L. 
amazonensis (Desjeux, 1996). 
 
Mucocutaneous leishmaniasis (MCL): 
Also called 'espundia', it produces disfiguring lesions to the face, destroying the 
mucous membranes of the nose, mouth and throat (Desjeux, 1996; WHO, 1998). It is 
mostly related to Leishmania species of the New World such as L. braziliensis, L. 
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 panamensis and L. guyanensis, but mucosal lesions have been reported in the Old 
World due to L. donovani, L. major and L. infantum in immunosupresed patients 
( Desjeux, 1996). Ninety percent of all cases of MCL occur in Bolivia, Brazil and Peru 
(WHO, 1996). 
 
Treatment: 1.1.3 
Accurate parasitological diagnosis is essential in leishmaniasis to determine the correct 
treatment. Some infections, especially simple cutaneous lesions due to L. major, are 
often self-healing and induce immunity to reinfection and treatment of these is 
generally not recommended, unless the lesions do not heal within 6-9 months. In case 
of chronic lesions due to L. tropica the treatment is based on pentavalent antimonials 
intramuscularly or intravenously at 10-20 mg/kg/day until cure.  
 
 Treatment of other forms, such as VL and MCL infections, mainly relies on the 
pentavalent antimonials sodium stibogluconate (Pentostam) or meglumine antimoniate 
(Glucantime), the first -line drugs except when resistance exists, and the usual dose is 
20 mg/kg/day for 30 days. They are expensive and need to be given by injection. The 
second-line drugs in case of resistance -amphotericin B and pentamidine, used in cases 
unresponsive to antimonials, need careful management to avoid serious side effects. 
They are used intravenously over several hours on alternate days from 0.1 mg/kg/day 
up to 1 mg/kg/day with a maximum total dose of 3g. For VL, aminosidine, alone or in 
association with pentavalent antimonials, has shown good efficacy but it is still under 
evaluation. Amphotericin B, included in liposomes, has proven to be very efficient but 
its use is still limited and expensive (Baily & Nandy, 1994; Desjeux, 1996; WHO, 
1998).  
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PKDL cases should be given high priority as they are considered to be residual 
reservoir, able to disseminate the disease. Patients should be treated by pentavalent 
antimonials at 20 mg/kg/day for 3 to 4 months (Desjeux, 1996). 
 
Parasite and life cycle: 1.1.4 
The life cycle of Leishmania species is commonly viewed as consisting simply of two 
different morphological stages: the intracellular amastigote in the vertebrate host and 
the extracellular promastigote in the invertebrate host (Molyneux & Killick-Kendrick, 
1987; Hommel, 1999). Briefly, the female sandfly picks up infected cells from the skin 
with their blood meal. The amastigotes are released in the midgut of the insect, 
transform to the procyclic stage and start multiplying actively without penetrating the 
hemocoele. After few days, numerous procyclic conquer the gut of the insect. Then the 
elongated procyclic promastigote attach to the midgut epithelium by inserting their 
long flagella between the microvilli that line the midgut. They migrate to the cardiac 
valve, where they transform into short, spherical, non-dividing promastigotes. Then the 
parasites are released from the midgut and penetrate the pharynx (proboscis) as 
metacyclic promastigotes, also termed paramastigote. From proboscis the metacyclic 
promastigotes are ousted to the new mammalian host. 
 
Metacyclic promastigotes enter the skin of the vertebrate host when the infected 
sandfly takes its blood meal. It may inoculate 10-200 promastigotes into the dermis. 
Within the macrophages and related cell types, they rapidly transform into amastigotes, 
remain within the phagocytic vacuole, where they develops and multiply, at some 
stage this infected cell, which may harbour up to 20 or more amastigotes, bursts and 
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 released free amastigotes, which infect other cells. Infected macrophages move from 
the skin to other tissues, infecting the spleen, liver and bone marrow, while certain 
parasites exhibit a specific tropism for each given host e.g. viscerotropism or 
dermatotropism. The features that control this tropism has not yet been elucidated but 
are thought to include, both host and parasite genetics as well as the status of immunity 
(Molyneux & Killick-Kendrick, 1987; Hommel, 1999). 
 
Most leishmaniasis are zoonotic (transmitted to humans from animal, reservoir hosts), 
and humans become infected only when accidentally exposed to the  transmitting 
sandflies. However, in the anthroponotic form (those transmitted from human to 
human through the sandfly vector), humans are probably the sole reservoir host (WHO, 
1996). The reservoir of L. infantum and L. chagasi is usually dog, but in several Old 
World and New World foxes, rats, opossum or racoon dogs may also act as reservoirs 
in some areas. The reservoir of L. donovani is mainly humans (Hommel, 1999), 
although other species are incriminated in Africa e.g. Arvicanthis niloticus in Sudan 
(El-Hassan et al., 1995). Domestic dog is incriminated as a reservoir host of American 
cutaneous leishmaniasis caused by L. braziliensis, L. panamensis and L. peruviana 
(Reithinger & Davies, 1999). Gerbils (Psammomys obesus) have been implicated as a 
reservoirs host of L. major in different Asian countries (Elbihari & El-Hassan, 1987; 
Rioux et al., 1990; El-Sibae et al., 1993). Also Psammomys obesus is suspected as a 
reservoir host of L. major in Egypt (Morsy et al., 1996). 
 
The vector: 1.1.5 
Sandflies that are the vectors of Leishmania parasites are insects of the order Diptera, 
family Psychodidae, subfamily Phlebotominae of the genus Phlebotomus (Old World), 
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 Lutzomyia (New World). There are more sandfly species in the New World than the 
Old World and this is often quoted as the reason that there are more species of 
Leishmania in the New World (León et al., 1996). 
 
Vectors of L. donovani in which infection in the fly gut was confirmed are: P. 
argentipes in India, P. chinensis in China, P. pernicrosis in North Africa, Italy, France 
and Portugal, P. perfiliewi in Greece, P. orientalis in Sudan and Ethiopia, P. martini in 
Kenya (Le Blancq & Peters, 1986). L. infantum is transmitted by P. perniciosus, P. 
ariasi, P. perfiliewi and P. neglectus. L. chagasi is transmitted by the L. longipalpis 
(WHO, 1990). Sandflies usually repose during the day in burrows, tree hollows, caves 
or buildings. After sundown, they leave the shelters to remain active throughout the 
night. 
 
1.1.6 
1.1.6.1 
The Leishmania genome: 
Nuclear DNA: 
The study of trypanosomatid chromosomes has been done by pulse field gel 
electrophoresis (PFGE) and variations of this technique like the orthogonal field 
alternate gel electrophoresis (OFAGE), since there is no evidence available for typical 
chromosome condensation during mitosis (Bishop & Miles, 1987; Lighthall & 
Giannini, 1992; León et al., 1996). 
 
Several studies suggest that Leishmania chromosomes are mainly diploid (Lovannisci 
et al., 1984; Beverley et al, 1988), with some chromosomes being aneuploid (Bard, 
1989). Now diploidy of Leishmania is widely accepted (Wong, 1995). The most 
refined studies identified 22 to 33 chromosomes in different Leishmania species, a 
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 figure that is very likely an underestimate of the actual number of chromosomes (Bard, 
1989). León et al. (1996) reported that in both New and Old World different species 
exhibit number of chromosomes ranging between 20-25 pairs. However, Wincker et al. 
(1996) managed to characterize 36 chromosomes demonstrated in L. infantum and L. 
donovani. The chromosomes are linear between 200-4000kb in length and they possess 
telomeres but centromeres have not been identified (Lighthall & Giannini, 1992). 
Chromosome size variability is characteristic of some Leishmania species, even 
between homologus, chromosomes (Blaineau et al., 1991) which complicates the use 
of karyotype in taxonomic studies. Leishmania genes are often found to be organized 
in tandem arrays or at least to have 2 or more copies spread through the genome (Bard, 
1989). 
 
Kinetoplast DNA (kDNA): 1.1.6.2 
kDNA represents the mitochondrial DNA (mtDNA) of the kinetoplastida and 
corresponds to 10-20% of the total DNA (Simpson, 1987). It is a network of 
concatenated circular DNA, divided into 2 classes: the homogenous maxicircles (~25-
50 molecules of 20 kb) and the heterogeneous minicircles (~0.8kb), which has many 
copies (~104). The maxicircle is the functional counterpart of the mitochondrial DNA, 
nevertheless its role in the editing of Uracil residues into mRNA nucleotides has been 
demonstrated  (León, 1996). The minicircles encode guide RNAs (gRNA) for editing 
of cytoplasm oxidase subunit III mRNA (Sturm & Simpson, 1990). Also Singh & 
Rastogi (1999) describe an unprecedented finding in the variable region in one of the 
minicircles sequence classes of L. donovani, which is transcribed and translated to a 
protein product.  
 
13 
  
Classification of Leishmania species: 1.1.7 
1.1.8 
The genus Leishmania is divided in 2 subgenera based in the distribution of the 
parasite in the midgut of the sandfly vectors. In the subgenus Leishmania, the 
promastigotes develop in the midgut and foregut of the insect - section Suprapylaria-, 
whereas in the subgenus Viannia parasites are restricted to the hindgut -section 
Peripylaria- (Lainson & Shaw, 1987). Species of the subgenus Leishmania belong to 
the L. donovani complex (L. donovani, L. infantum, L. chagasi [American L. infantum], 
L. archibaldi); L. tropica complex (L. tropica, L. aethiopica, L. major) and L. 
mexicana complex (L. mexicana, L. amazonensis, L. pifanoi, L. garhami, L. 
venezuelensis). On the other hand, parasites of the subgenus Viannia only occur in the 
New World (Shaw, 1994). These are the species of L. braziliensis complex (L. 
guyanensis, L. naiffi, L. peruviana, L. panamensis and L. shawi). The 2 subgenera 
Leishmania and Viannia belong to the Kingdom Protista Haeckel, 1866; Sub-kingdom 
Protozoa Goldfuss, 1817; Phylum Sarcomastigophora Honigberg & Balamuth, 1963; 
Sub-phylum Mastigophora Deising, 1866; Class Zoomastigophorea Calkins, 1909; 
Order Kinetoplastida Honigberg, 1963, emend. Vickerman, 1976; Sub-order 
Trypanosomatina Kent, 1880; Family Trypanosomatidae Dolfein, 1901, emend. 
Grobben, 1905; Genus Leishmania Ross 1903 (Lainson & Shaw, 1987). 
 
Diagnosis of visceral leishmaniasis: 
Routine diagnosis of VL relies on a combination of the following methods (i) the 
clinical suspicion i.e. long-term unexplained fever, cachexia and hepatosplenomegaly 
(ii) microscopic detection of leishmanial amastigotes in stained smears of lymphnode, 
bone marrow or splenic aspirates (iii) the culture of the parasite (iv) immunological 
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 tests for the detection of anti-leishmanial antibodies and leishmanial antigenes and (v) 
molecular techniques including PCR. 
 
Microscopic finding of the parasite is considered the golden standard for diagnosis, 
although the method is relatively simple and cheap, it suffers from low sensitivity 
(Weiss, 1995; Osman et al., 1997), and there is no possibility to distinguish between 
leishmania amastigotes belonging to the different species (Neva & Sacks, 1990; Weiss, 
1995). It has been estimated that the sensitivity of microscopy may only be 50-85% 
when, a single specimen is examined by a competent microscopist (Hommel, 1999). 
Also microscopy suffers from low parasitaemia in the target organs (Wilson, 1991). 
Better results were obtained when using invitro culture, but the major drawbacks of 
culturing, especially under field conditions, is its vulnerability to contamination 
(Wilson, 1991; Oskam, et al., 1998). 
 
Serological tests reveal the presence of antibody and are useful in both individual 
diagnosis and epidemiological surveys. A number of methods have been described 
(extensively reviewed by Kar, 1995), including indirect immunofluoresent antibody 
test, IFAT, (Badaro et al., 1983; Pappas et al., 1985); enzyme- linked immunosorbent 
assay, ELISA, (Hommel et al., 1978; Pappas et al., 1985); direct agglutination tests, 
DAT, (Harith et al., 1986 & 88; Meredith, et al., 1995; Hommel et al., 1997), and a 
variety of immunoblotting methods (Evans & Pearson, 1988; Rolland et al., 1994). 
There are various problems with serological assays, including the fact that persistence 
of antibodies may be a problem in endemic area; certain individuals may have a high 
level of reactive antibodies in the absence of the organism (false positive), conversely 
anti-parasite antibodies when induced may not be present until some time after the 
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 initiation of infection (false negative). The possible cross-reactivity with other 
pathogens, e.g. malaria, trypanosomiasis, schistosomiasis and leprosy (Abdallah, 1980) 
and the fact that most serological tests cannot readily distinguish between current, 
subclinical or past infections (Hommel et al., 1997). The performance of serological 
tests is particularly poor in patients co- infected with HIV (Hommel, 1999). 
 
Recently, several molecular biological techniques have been developed for the 
sensitive detection and identification of pathogens. The main approaches to nucleic-
acid-based detection are (i) hybridization using DNA probes (ii) amplification 
techniques including the polymerase chain reaction (PCR) for the detection of DNA, 
nucleic acid sequence based amplification (NASBA) and reverse-transcriptase PCR 
(RT-PCR) for the detection of RNA. 
 
PCR, which is used in this study, is a technique, which allows the sensitive, specific 
and fast detection of minute amounts of pathogen DNA. PCR is based on the 
amplification of a known, specific sequence using oligonucleotide primers (typically 
20-mers), which specifically bind to the DNA flanking the region of interest. Then the 
target sequence is amplified using a heat-stable DNA polymerase isolated from 
Thermus aquaticus (Saiki et al., 1988). The amplification procedure consists of 
denaturation of a double stranded DNA, annealing and extension that results in 
thousands of copies of DNA. This technique is useful in detecting infections with low 
parasites level. 
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1.1.9 
1.1.9.1 
Identification and characterization of Leishmania: 
Phenotypic and immunological methods: 
Leishmania organisms have been classified as different species primarily on the basis 
of clinical, biological, geographical and epidemiological criteria. During the last 
decade a number of methods have become available for the differentiation of 
Leishmania isolates. For epidemiological purposes, the most useful taxonomic 
techniques has long been isoenzyme analysis (Miles et al., 1980; Evans et al., 1984; 
WHO, 1990; Andresen et al., 1996). The technique still remains the ‘gold standard’ for 
Leishmania taxonomy and its principal advantage is to provide a stable marker for 
clusters of geographical isolates within each given species (Hommel, 1999). However, 
it is restricted in the way that, it assays the genotype indirectly, so that nucleotide 
substitutions that do not change the amino acid composition remain undetected, 
changes in the amino acid composition that do not change the electrophoretic mobility 
may also be not observed (Lewin, 2000). Further more isoenzyme analysis is slow, 
laborious, and expensive, requiring cultivation of the isolates and the estimation of the 
profiles of 10-20 different enzymes (Andresen et al., 1996; Noyes et al., 1996). Other 
techniques include monoclonal antibodies, which are currently being assessed to 
identify New World species but suffer from their relative lack of specificity for isolates 
from widely spread foci (McMahon-Pratt & David, 1981; Noyes et al., 1996).  
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1.1.9.2 Molecular biological methods: 
Different DNA-based methods have been used for characterization of isolates of 
Leishmania at  
 
(a) Genus level: by performing PCR using Leishmania common primers depending on 
direct identification of the parasite in clinical materials (Uliana et al., 1991; Hassan et 
al., 1993; Piarroux et al., 1993 & 1994; Andresen et al., 1997; Osman et al., 1997 & 
1998).  
 
(b) Species level: different methods could be applied, such as PCR which depends on 
species specific primers (Ibrahim et al., 1994), analysis of restriction fragment length 
polymorphism (RFLP), where the substrate can be whole genomic DNA, kDNA or 
PCR amplification products, analysis of kinetoplast and nuclear DNA including 
Southern blot hybridisation with specific DNA probes (Jackson et al., 1984; Beverley 
et al., 1987; Barker, 1989; Van Eys et al., 1989&1991), DNA fingerprinting using 
DNA probes complementary to repetitive DNA sequences (Macedo et al., 1992), PCR 
fingerprinting approaches using single arbitrary or non-specific primers (Williams et 
al., 1990; Tibayrenc et al.,1993; Pogue et al., 1995a&b; Schönian et al, 1996),  
molecular karyotyping (Lighthall and Giannini,1992) and sequencing of species 
specific genes e.g. sequence of the first part of ITS (located between the small subunit 
rRNA and the 5.8S rRNA genes), obtained at Microbiology laboratory, Institüt fur 
Microbiologie und Hygiene, Berlin, Germany, are found to be almost species specific. 
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 (c) Strain level: these methods are capable to detect  variation among isolates of 
Leishmania belonging to the same species such as sequencing, PCR-fingerprinting 
approach which uses single non specific primers and the restriction analysis of the 
amplified ITS region (Schönian et al., 2000; Schönian et al., 2001), single-stranded 
conformation polymorphisms, SSCP (Van Eyes et al., 1992; Lewin, 2000). 
 
High levels of intra- and inter-species variation were observed in New World 
Leishmania species of the Viannia subgenus by amplifying and restricting the rapidly 
evolving internal transcribed spacers (ITS) in the ribosomal operons. Using this 
aproach it has been made possible to distinguish species and strains of New World 
Leishmania isolates based on their characteristic restriction patterns (Cupolillo et al., 
1995). However, the disadvantage of this technique is that it detects either point 
mutations that affect the restriction site or deletions or insertions which change the size 
of the fragment (Orita et al., 1989). To obtain information about the part of the 
sequence not covered by this analysis, other techniques must be employed. 
 
PCR fingerprinting methods do not depend upon previous knowledge or availability of 
the DNA sequence of the target (Welsh & McCllelland, 1990; Williams et al., 1990; 
Tibayrenc et al., 1993). Using these PCR techniques, detection of genetic 
polymorphisms among species and strains of Leishmania has been described (Pogue et 
al., 1995a&b; Noyes et al., 1996; Schönian et al., 1996). However, these methods can 
only be used on cultured parasites. Contaminating host DNA would mask the signal 
from the parasite DNA (Noyes et al., 1996).  
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 Analysis of kinetoplast sequences as well as of electrophoretic karyotyping have 
proven less reliable for identifying Leishmania isolates because extensive 
polymorphism has been observed by these methods among strains of the same species 
(Rogers & Wirth, 1987; Bishop & Akinsehinwa, 1989; Bastien et al., 1990; 
Henriksson et al., 1996; Wincker et al., 1997). 
 
Direct DNA sequencing of PCR products is another approach commonly used for 
development of typing methods, population genetic studies, designing specific primer 
and detection of sequence variation in a particular gene (Bevan et al., 1992; Reddy, 
1995). Although it is possible to detect polymorphisms in a sequence, it is not possible 
to separate and hence define the number of sequence variants, if significant levels of 
size and sequence heterogeneity exist in a particular DNA e.g. (hypervariable region of 
DNA) then it may be difficult or even impossible to read a sequence (Gasser & Chilton, 
1995). To overcome this problem PCR products are usually cloned into a plasmid 
vector. Once PCR product is cloned, it may be a tedious and time consuming (Gasser, 
1997). Although nucleic acid sequencing is the most informative technique available 
for genotypic studies, it is labour intensive, difficult and expensive. Sequencing can be 
faster and easier if an automated sequencer is used. 
 
PCR- based mutation scanning techniques provide powerful alternatives for studying 
genetic variation in populations (Cotton, 1993; Lessa & Applebaum, 1993). These 
methods, which rely on  physical properties or the modification of DNA molecules of 
the same or very similar size, that differ by one or more nucleotides, their excellent 
capacity and potentiality to resolve sequence variability has not been exploited for the 
study of genetic variation in parasites (Gasser, 1997). 
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 Single-stranded conformation polymorphisms (SSCP) analysis has been developed to 
scan genes for single base differences which could be useful as genetic markers (Orita 
et al., 1989; Gasser, 1997; Gasser & Zhu, 1999). This method relies mainly on the 
principle that the electrophoretic mobility of a single-stranded DNA molecule in a non-
denaturing gel is dependant on its structure and sizes (length). The single stranded 
molecules have secondary and tertiary structures (conformations) as a result of base 
pairing between complementary nucleotides within each strand. SSCP showed species-
specific patterns as well as intra-species variation in an entomological study (Hiss et 
al., 1994). So far, only a single report describes the use of isotopic SSCP as a tool for 
the identification of Leishmania at the complex level based on the observation of point 
mutations in the central part of the SSU rRNA genes (Van Eys et al., 1992). 
 
Leishmaniasis in the Sudan: 1.2 
Sudan is considered as one of the most important areas of leishmaniasis in the world 
where sharp epidemics involving thousands of people with many deaths were recorded. 
All forms of leishmaniasis i.e. CL, MCL, VL and PKDL occur in Sudan. This group of 
diseases causes serious economic loss in the country, both in terms of the disability of 
affected individuals and in the cost of treatment, especially as most of those with 
leishmaniasis are on low incomes and live in rural areas. 
 
Visceral leishmaniasis (VL) is the one of the most important endemic diseases in the 
country and is known to occur in the Sudan since 1904 when Neave (1904) described 
the first patient in the country. The main endemic area is in the eastern part of the 
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 country, from the banks of the White Nile in the West to the Ethiopian border in the 
East, and from Kassala in the North towards Malakal in the South see Fig.(1). Other 
smaller foci have also been described in Kapoeta in Equatoria and parts of Kordofan 
and Darfur provinces. Occasional severe outbreaks occur, like the one in the southern 
Fung in Blue Nile province in 1956-1960, which caused thousands of death (Sati, 
1958). An outbreak of kala-azar was reported in Khartoum among displaced people (de 
Beer et al, 1990). Also, epidemics have occurred in recent years in war zones of 
southern Sudan where about 100,000 people died of leishmaniasis since 1984 (Seaman 
et al, 1996). Recently Roberts et al. (2000) reported that more than 10% of the 
population in southern Sudan died from visceral leishmaniasis over the past 5 years. 
Zeese and Frank (1987) estimated that of the total number of 1300 patients reported 
annually in the Sudan, more than 75% were treated in the hospitals of Gedaref and 
Hawata, a small rural town ~100km south to Gedaref, situated along the Rahad River.  
 
L. donovani senso lato is incriminated as the aetiological agent of VL (Hoogstraal & 
heyneman, 1969; El- Hassan et al., 1995). The incubation period of kala-azar appears 
to be between 2 months to 2 years (Zijlstra et al., 1991). P. orientalis is the only 
known proven vector of kala-azar in the Sudan (Hoogstraal & Heyneman, 1969; 
Elnaiem et al., 1997). However, in the Kapoeta area in South Sudan, where P. 
orientalis is not known to be present P. martini may be the main vector of VL (Miniter 
et al, 1962). The Nile Rat (Arvicanthis niloticus) is being incriminated as the reservoir 
host for VL in Sudan (Hoogstraal & Heyneman, 1969; El- Hassan et al., 1995).   
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Figure 1: Endemic areas of visceral and cutaneous leishmaniasis in Sudan. 
 : Study area 
\\\\\ : Cutaneous leishmaniasis 
#### : Visceral leishmaniasis 
 
Also Hoogstraal & Heyneman, (1969) reported the rodent Acomys aligena, The Spiny 
Mouse and two species of carnivores: Genetta g. senegalensis, The Senegal Genet and 
Felis serval phillipsi, The Sudanese Serval Cat to be infected.  
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 The diagnosis of kala-azar is classically made on clinical grounds as well as 
parasitologically by examination of smears of lymph node, bone marrow or splenic 
aspirates. Lymph node aspirate has been recommended as a safe procedure with 
sensitivity of 78% in Sudanese kala-azar (Siddig et al., 1989). However, other 
serological tests were applied such as the enzyme- linked immunosorbent assay 
(ELISA) and the direct agglutination test -DAT- (Harith et al., 1986; El-Safi & Evans, 
1989). Recently the PCR has been introduced for the diagnosis of leishmaniasis 
(Osman et al., 1997).  
 
Kirk & Sati (1947) introduced the treatment of kala-azar with sodium stibogluconate in 
the Sudan and antimony is well established as the drug of choice (Zijlstra et al., 1993). 
The only drugs affordable in poor countries are the pentavalent antimonials. Drug costs 
vary between about $20 and $200 for treating an average patient.  
 
Post kala-azar dermal leishmaniasis (PKDL) is a known complication of VL in Sudan, 
although cases without previous history of kala-azar were reported in Sudan (El-
Hassan et al., 1992). 
 
Cutaneous leishmaniasis (CL) is common in the North and is characterized by ulcers in 
the skin that usually self heal, leaving a scar. In recent years a major epidemic occurred 
in large parts of northern Sudan, causing thousands of cases (El-Safi & Peters, 1991). 
CL is caused by L. major (Abdallah et al., 1973). P. papatasi was incriminated as a 
vector for CL (Abdallah & Sherif, 1978). Arvicanthis niloticus is believed to be the 
reservoir of cutaneous leishmaniasis in the Khartoum area (El-Safi & Peters, 1991). 
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 Mucocutaneous leishmaniasis (MCL) in the Sudan is a rare condition, less than 100 
cases have been described. The condition may be caused by L. major or it may follow 
kala-azar, which is caused by L. donovani (Ghalib et al., 1992).  
1.3 
1.3.1 
Selection of genomic targets for the differentiation of 
species and strains of Leishmania: 
Studies involving PCR, sequencing and SSCP require the selection of appropriate 
areas of genome that must be chosen with respect to variability. Sequences coding for 
vital proteins or RNAs are useful for comparing between distantly related taxa, 
because they are highly conserved. On the contrary, genes for proteins with antigenic 
properties can be expected to vary considerably, thus making their use difficult, but 
they can give valuable information on adaptation and speciation. Likewise, intergenic 
regions that are expected to vary randomly since they are not influenced by natural 
selection are the most useful for determination of temporal distance. The following 
genomic regions were targeted in this study. 
 
Ribosomal internal transcribed spacer (ITS): 
Leishmania rRNA genes are found as a tandem repeat units separated by a non-
transcribed spacer (NTS) regions. The units are composed of the small sub-unit (SSU) 
rRNA, 5.8S rRNA and of the large sub-unit (LSU) rRNA genes which are highly 
conserved in Leishmania. These coding regions are separated by an internal 
transcribed spacers (ITS). Both NTS and the ITS regions show extensive variability 
(Cupolillo et al., 1995). ITS is particularly interesting for its relatively small size (~ 1 
kb in Leishmania). It is flanked by highly conserved segments to which PCR primers 
can be designed (Cupolillo et al., 1995).  
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gp63 genes: 1.3.2 
Gp63 is a surface glycolipid-anchored zinc protease of approximately, 63 kDa present 
in all Leishmania species (Roberts et al., 1993). It has been demonstrated that Gp63 is 
present in both the promastigote and amastigote life stages of Leishmania (Frommel et 
al., 1990). Also it is known as a major surface protease (msp). This molecule is 
important for both, the entry of the parasite to the mammalian macrophages and its 
survival within the macrophage phagolysomes (Wilson et al., 1989; Bordier, 1987).   
 
Although the gp63 gene organization has a different degree of complexity among 
various Leishmania species and even within the same species it forms, in general, a 
family whose members are distributed in tandem arrays along the genome with varying 
copy numbers (Morales et al., 1997). In L. chagasi the genes are described to be 
arranged in 3 distinct classes (Ramamoorthy et al., 1992). 
 
 Low virulent promastigotes in early logarithmic phase of growth, express gp63 RNA 
of 2.7 kb (mspL); where as the highly virulent stationary phase promastigotes contain 
gp63 RNA of 3.0 kb (mspS). Cells in intermediate stages of growth have varying 
amounts of both the RNA classes. Constitutively expressed RNAs of 2.6 and 3.1 kb 
which form the third class mspC are also present at constant low levels throughout the 
promastigote growth cycle  (Ramamoorthy et al., 1992). The organizations of the gp63 
genes in several other Leishmania species have been investigated. In L. donovani at 
least 7 tandem genes as 3 kb repeats are separated from a single gene down stream and 
at least 2 other genes occur elsewhere (Webb et al., 1991). The finding that multiple 
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 gp63 genes occur within a species indicates that different forms of the protein might be 
expressed (Roberts et al., 1993).  
 
Anonymous DNA regions: 1.3.3 
1.4 
All anonymous DNA regions targeted in this study are nuclear genes, specific for 
Leishmania and represent single copy genes with exception of one marker (LK413) 
which is found in 2 chromosomes. These codominant anonymous markers namely 
L0110, L510, L413, LK413, L0308 and L0114 are characterized by small sizes 
ranging between 120 and 580 base pairs and are located at chromosomes number 29, 
33, 14, 13 &26, 28 and 34, respectively. These genes do not show any homology to 
known genes of Leishmania found in data bank. Primers for these randomly amplified 
targets are developed at the Institüt für Mikrobiologie und Hygiene, Berlin, Germany 
as described by Lewin (2000) for population genetic studies. 
 
 
Objectives of this study: 
Correct diagnosis and identification of the parasite are crucial for choosing the 
effective treatment against different forms of leishmaniasis, for epidemiological and 
population genetic studies and for development of genetic markers. Therefore 
diagnosis of causative agent of visceral leishmaniasis must now contemplate typing of 
the organism. These typing methods should be quick, easy to perform, produce results 
from low parasites number and contaminated samples to be performed particularly in 
endemic regions of developing countries, especially like the situation in this study 
where the samples were collected under field conditions in remote rural areas. This 
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 study tried mainly to contribute towards development and evaluation of sensitive 
methods based on amplification of parasite DNA directly from clinical samples 
without prior culturing. For the above mentioned reasons this work aimed towards 
 
1. To evaluate the performance of the nested PCR based on the detection of the Leishmania 
ITS1 rRNA gene, directly from biological materials spotted on filter papers as a diagnostic 
tool. 
2. To examine genetic heterogeneity among the causative agents of visceral leishmaniasis in 
some endemic Sudanese leishmaniasis foci directly from biological materials spotted on 
filter papers. Mainly the internal transcribed spacer (ITS), has been utilized. Also some 
other gene loci have been targeted such as the gene coding for the antigenic proteins 
(gp63) and other 6 anonymous DNA regions. Then to evaluate the use of these mentioned 
PCR products as potential genetic markers for strain differentiation using SSCP technique. 
3. To compare 3 PCR based methods (in order to screen for genetic variability within the 
causative agents of VL and PKDL in eastern Sudan) namely PCR-fingerprinting as well as 
PCR-RFLP and PCR- SSCP utilizing ITS as a target and to correlate the data obtained by 
the 3 methods and to validate the results by sequencing. 
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2 Materials and Methods 
 
2.1 
2.2 
Study area: 
This study was carried out in clusters of villages that represent an endemic focus of 
visceral leishmaniasis (VL). These villages were located in Gedaref State, eastern 
Sudan (Figure 1). The disease is well known among people in these villages as kala-
azar. The climate of the study area is tropical and could be divided through the year 
into a hot dry summer (March-June), a warm wet autumn (July-October) and a 
moderately warm winter (November-February). The average minimum/maximum 
temperature of the area is 28/44oC in summer and 18/34oC in autumn and winter, with 
annual rainfall of about 600mm. 
 
This study area is generally characterised by reduced vegetation and grass with 
scattered Acacia trees. The area is flat and composed of cracked alluvial clay soil. 
People usually live in huts constructed of wood, bamboo and grass (Figure 2). The 
villages are surrounded by large scale sorghum and sesame fields. Inhabitants mainly 
work as farmers, woodcutters, and shepherds. Many nomadic tribes roam the area. 
 
Samples collection: 
Clinical samples were collected from 100 patients suspected of having kala-azar 
(patients in whom parasites were not demonstrated microscopically, but who had 
clinical symptoms and signs suggestive of (VL) or post kala-azar dermal leishmaniasis 
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 (PKDL). These patients had at least one of the following features: fever for more than 
two months, left upper quadrant abdominal pain lymphadenopathy, splenomegaly, 
wasting or nodules and papules on the skin in case of PKDL. When kala-azar was 
suspected, inguinal lymph node aspiration was performed and Giemsa-stained thin 
films were examined for Leishmania parasites; if negative or when no palpable lymph 
nodes were present, a bone marrow aspiration was performed and the marrow was also 
microscopically examined. In case of PKDL, skin smear was examined. 
 
 
Figure 2: A picture of the endemic villages showing the construction of living places and the 
cracked clay soil. 
 
30 
 The clinical samples were collected from Gedaref hospital (the main referral hospital 
in the area), Gedaref clinic (Gedaref State, eastern Sudan, 411 km from Khartoum) as 
outpatients and from kala-azar suspected patients in their villages between April 1997 
and November 1998. All patients were originating from an endemic area in eastern 
Sudan. In total 71 cases were found to be microscopically positive. Only the 
microscopically confirmed kala-azar cases (patients in whom Leishmania amastigotes 
were demonstrated by microscopy on either lymph node or bone marrow aspirates) 
were included in this study for molecular characterization purposes. The remaining 29 
were included for diagnostic purposes to compare the microscopic method with the 
polymerase chain reaction (PCR) method for detection of Leishmania parasite. 
 
About 30µl from inguinal lymph node, bone marrow aspirates or skin scraping were 
collected and spotted on Whatman filter paper #3. Each filter paper sample was stored 
in a separate polyethylene bag at room temperature for further molecular biological 
analysis. Five samples were collected from lymph node aspirate from Sudanese 
patients who had diseases other than VL and were used as negative control. 
 
Forty from the 71 microscopically positive aspirates were simultaneously attempted 
for culturing. In this case part of the aspirate was also aseptically inoculated into 2 
tubes containing NNN (1.4% agar, 0.6% NaCl) and Difco 4N (4% difco 4N blood 
agar) media, respectively. These media were prepared as described by Evans (1989). 
10 ml of defibrinated rabbit blood containing 100 µl gentamicin solution were added to 
100 ml of the previous melted medium. 2 ml of either NNN or Difco 4N media were 
distributed into small sterile tubes, then kept in sloped position until the agar solidified. 
The tubes were stored in 4oC until use. Just before inoculation 200 µl of 0.9% NaCl 
31 
 were added to each tube. The cultures were kept at ambient temperature 25oC and 
transported to Institüt für Mikrobiologie und Hygiene, Humboldt-Universität zu Berlin, 
Germany for further sub-culturing in RPMI 1640 medium supplemented with 15% 
fetal bovine serum and 100 µg/ml penicillin and 100 µg/ml streptomycin. These 
cultures were sub-cultured weekly (1 ml from the previous culture plus 10 ml from the 
RPMI medium). 
 
Structural questionnaire filled in by; direct interview for each patient was used for 
collection of demographic and clinical information. This questionnaire covered the 
following topics: name of the patient, patient code, sex, age, tribe, residence (usual 
place of residence and present residence), date of isolation of the parasite, clinical 
symptoms, microscopy test and stage of treatment. 
 
DNA isolated from further 18 Leishmania donovani strains used in this study were 
obtained from the collection of the Royal Tropical Institute, Amsterdam. Twelve of 
them were isolated from the same above-mentioned endemic study area in eastern 
Sudan (Gedaref State). Six were WHO references namely, MHOM/KE/85/NLB323, 
MHOM/IN/71/LRC-L51a, MHOM/CN/??/Wangjie1, MHOM/SD/75/LV139, 
MHOM/SD/68/1S and MHOM/SD/62/LRC-L61. 
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 2.3 
2.3.1 
DNA extraction: 
DNA extraction from clinical samples spotted on filter 
papers: 
DNA was isolated as described previously by Meredith et al. (1993). Briefly, filter 
papers with spotted biological material (Lymph node, bone marrow aspirates and skin 
smear) were punched out with a paper puncher. After each sample was obtained a 
clean sheet of paper sprayed with 90% alcohol was punched 10 times in order to 
prevent DNA contamination from one sample to the next. Two punched out discs 
(approximately 15 µl of aspirate) were placed in 250 µl lysis buffer (50 mM NaCl, 50 
mM Tris- HCl; 10 mM EDTA pH 7.4; 1% {vol/vol} Triton X-100; 200 µg of 
Proteinase K per ml) and incubated in water bath for 3 hours or overnight at 60oC. 
Thereafter the mixture was subjected to phenol -chloroform extraction. An equal 
volume of bufferd phenol was added, shaked gently for 10 minutes and centrifuged at 
13000 rpm. The upper water phase was then transferred to a new 1.5 ml eppendorf 
tube containing an equal volume of chloroform-isoamyl alcohol (24:1), shaked and 
centrifuged as mentioned above. Again the upper water phase (±250 µl) was extracted 
and for precipitation 1/10 volume of 3M NaAc and 2 volumes of absolute ethanol were 
added. The tubes were left overnight at - 20oC. Thereafter, samples were centrifuged 
for 15 minutes at 12000 rpm. DNA pellets were washed with 70% ethanol then dried 
using speed vacuum dryer (Speed Vac, Savant, Hicksville, NY, USA) for 5 minutes. 
The dry pellets were then resuspended in 50 µl TE buffer (10mM Tris; 1mM EDTA 
pH 7.5) and stored at 4oC until use. 
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 DNA extraction from cultured Leishmania: 2.3.2 
2.4 
2.4.1 
DNA was isolated from 8 successful cultures as described previously by Schönian et al. 
(1996) with slight modifications, 2 ml cultured cells were suspended in 5 ml Net buffer 
(50 mM NaCl; 10 mM EDTA; 50 mM Tris- HCl pH 7.4). Sodium dodecyl sulphate 
(SDS) was added to a final concentration of 0.5% and the mixture was shaked until the 
solution was viscous. RNase was added to a concentration of 100 µg/ml and the 
mixture was incubated in a water bath for 30 min at 60oC. Proteinase K was added to a 
final concentration of 100µg/ml and the samples were incubated again at 60oC in a 
water bath for 3 hours or overnight. Then samples were subjected to 
phenol/chloroform extraction, precipitation with NaAc and ethanol and redissolution in 
200 µl TE buffer as described above for extraction of DNA from filter papers. The 
DNA concentration was measured spectrophotometrically using UV/ Visible 
Spectrophotometer (Pharmacia LKB. Ultrospec 111). 
 
PCR amplification: 
Internal transcribed spacer (ITS): 
The entire ITS region was amplified with the following leishmania specific primers: 
LITSR (5’ -CTGGATCATTTTCCGATG-3’) and LITSV (5’-
ACACTCAGGTCTGTAAAC-3’). No amplification products were observed when 
human, Trypanosoma cruzi, Escherichia coli, Candida albicans, Trychophyton 
terrestre and Microsporum audouinii DNA was used as template in this PCR approach. 
The ITS1 and ITS2 regions (see Figure 3) were separately amplified with the  
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 primerpairs L5.8S (5’- TGATACCACTTATCGCACTT-3’)/LITSR and L5.8SR/ (5’-
AAGTGCGATAAGTGGTA-3’)/LITSV; respectively. Primers were synthesized 
commercially (TIB-MOLBIOL, Berlin, Germany). 
 
 
Figure 3: The position of the internal transcribed spacer (ITS) in the ribosomal operon 
amplified with leishmania specific primers. Primer sequences are given in the text. 
 
For SSCP and sequence analysis the two parts of the ITS2, A and B (Figure 3) were 
amplified separately using the primer combinations LIS2MR (5’- 
AGAGTGCATGTGTGTAT-3’)/ L5.8SR and LIS2MV (5’-
ATACACACATGCACTCTC-3’)/ LITSV, respectively. 
 
Amplification reactions were performed in volumes of 50 µl. 3 µl DNA or 1 µl DNA 
(for nested PCR) were added to a PCR mix containing 200 µM of each dNTP 
(Pharmacia Biotech, USA); 1x PCR buffer (10 mM Tris-HCl, pH 8.0; 50 mM KCl; 1.5 
mM MgCl2); 2 U Taq polymerase (Perkin Elmer, Roche Molecualr System, USA) and 
25 pmol of each primer. Samples were overlaid with sterile, light mineral oil (Sigma, 
Deisenhofen, Germany) and amplified as follows: initial denaturation at 95oC for 2 
min followed by 34 cycles consisting of denaturation at 95oC for 20 sec, annealing at 
53oC for primer pairs LITSR/LITSV; LISTR/L5.8S and LITSV/L5.8SR or at 57oC for 
primer pairs LITSV/LIS2MV and L5.8SR/LIS2MR for 30 sec and extension at 72oC 
for 1min. This was followed by a final extension cycle at 72oC for 6 min. 
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PCR was run in Robocycler Gradient 40, Stratagene. Amplification products were 
subjected to electrophoresis in 1% agarose NA (Pharmacia Biotech AB, Uppsala, 
Sweden) at 100 Volts in 0.5x TBE buffer (0.023 M Tris-borate, 0.5 mM EDTA) and 
visualized under UV light after staining for 15 min in ethidium bromide (0.5 µg/ml). 
One kilo base pairs (1kbp) DNA ladder (Life Tech, USA), was used as a molecular 
size marker. Amplified PCR products were documented by photography (on Polaroid 
films, USA) or by a camera (Gene Eagle eye 11, Stratagene, Heidelberg). 
 
Nested PCR was performed to obtain sufficient PCR products for subsequent single-
stranded conformation polymorphisms (SSCP) analysis or sequencing. ITS1 and ITS2 
were amplified by nested PCR from previous ITS PCR products and, ITS2 A and B 
from ITS2 products. 
 
Major surface protease msp (gp63) gene: 2.4.2 
To design primers for the amplification of gp63 sequences, sequences of L. donovani, 
L. infantum, L. chagasi and L. major as well as of different classes of gp63 genes (S, L 
& C) that were submitted to Gene Bank were aligned. Then primer sequences were 
designed from the highly conserved regions (with close annealing temperature, 
according to the equation {4(G+C) +2(A+T)}-3 to 5oC across the above mentioned 
species. Part of the coding region of the gp63 gene (from position 445-461 to position 
1802-1817) was amplified with the following primers: gp63-1 (5’-
TCCACCGAGGACCTCACCGA-3’) and gp63-6 (5’-
CTGGCACACCTCCACGTACG-3’). For SSCP and sequence analysis (Figure 4), this 
part was divided into 3 parts X (from position 445-461 to position 869-887), Y (from 
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 position 850-868 to position 1209-1224) and Z (from position 1189-1204 to position 
1802-1817), which were amplified separately using the primer combinations gp63-
1/gp63-2 (5’-GTCGTACCGCGACGCAATGT-3’); gp63-3(5-
ACATTGCGTCGCGGTACGAC-3\)/gp63-4 (5’-GTAGAAGCCGAGGTCCTGGA-
3’) and gp63-5 (5’-TCCAGGACCTCGGCTTCTAC-3’)/GP63-6, respectively. These 
primers were synthesised commercially (TIB-MOLBOL, Berlin, Germany). 
 
 
 
gp63-1
gp63-3
gp63-5
gp63-6gp63-4gp63-2
 
Figure 4: Schematic presentation showing the division of gp63 gene into 3 parts. Primer 
sequences are given in the text. 
 
Amplification reactions were performed in volumes of 50 µl. 3 µl DNA were added to 
a PCR mix containing 200 µM of each dNTP (Pharmacia Biotech, USA); 1x PCR 
buffer (10 mM Tris-HCl, pH 8.0; 50 mM KCl; 1.5 mM MgCl2); 2.5 U Taq polymerase 
(Perkin Elmer, Roche Molecular System, USA) and 10 pmol of each primer. Samples 
were overlaid with sterile, light mineral oil (Sigma, Deisenhofen, Germany) and 
amplified as follows; initial denaturation at 94oC for 3 min followed by 30 cycles 
consisting of denaturation at 94oC for 30 sec, annealing at 63oC for primer pairs gp63-
1/gp63-6 and gp63-1/gp63-2; at 64oC for primer pairs gp63-3/gp63-4 and at 65oC for 
the primer pairs gp63-5/gp63-6 for 30 sec and extension at 72oC for 1 min. This was 
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 followed by a final extension cycle at 72oC for 6 min. PCR was run in Robocycler 
Gradient 40, Stratagene. Visualization and documentation of PCR products were 
performed as mentioned above for ITS region. 
 
To obtain enough PCR products for subsequent SSCP analysis or sequencing, X, Y 
and Z regions were amplified by nested PCR from previous XYZ region. 
 
Anonymous DNA markers: 2.4.3 
Six anonymous DNA regions were amplified, using primers developed at the Institüt 
für Mikrobiologie und Hygiene, Humboldt Universität zu Berlin as described by 
(Lewin, 2000) for population genetic studies in Leishmania. These primers were 
synthesized commercially (TIB-MOLBIOL, Berlin, Germany). The primer sequences 
and the PCR conditions were shown in table (1).  
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Table 1: Specific primer pairs and PCR conditions (per 50 µl) for the amplification of 
anonymous DNA markers. One U Taq polymerase and 1x PCR buffer (10 mM Tris-HCl, pH 
8.0; 50 mM KCl; 1.5 mM MgCl2) were added into all reactions. 
Prime 
pair 
Sequence Primer 
each pmol 
DNTPs 
µM 
DNA 
ng 
Annealing 
temp.oC. 
cycles 
L413H 
L413R 
5’-CTCACGCTTTGTGCTTGTGT-3’ 
5’-CAACAAGGCGTATTTCCACG-3’ 
15 50 6 54 30 
L0114H 
L0114R 
5’-CTACCAAGAAGGGTGGCAAG-3’ 
5’-GGTGCAGTACTCGTACCTAC-3’ 
60 200 8 51 34 
LK413H 
LK413R 
5’-ACAGACGTACACACGGGC-3’ 
5’-TCGTCTTCTTGTTGCTTGCC-3’ 
15 50 6 50 31 
L510H 
L510R 
5’-ATAGGTTAACGGCAACGCAC-3’ 
5’-TGACAGAGACACACAACGAC-3’ 
30 100 10 52 34 
L0308H 
L0308R 
5’-ACACCATTCACGGCAGGCAA-3’ 
5’-CCCTCAATCTCTACCTCCAC-3’ 
60 200 8 52 34 
L0110H 
L0110R 
5’-GGCAAAGAAAAAGAGCAGCG-3’ 
5’-CTTGTCGTGCGTTGAATATC-3’ 
15 100 6 50 34 
 
All amplification reactions were performed in volumes of 50 µl and amplified as 
follows; initial denaturation at 95oC for 3 min followed by number of cycles depending 
on the primer (Table 1). These cycles consist of denaturation at 94oC for 1 min, 
annealing temperature (Table 1) for 30 sec; extension at 72oC for 1 min and a final 
extension at 72oC for 5 min. Amplification reactions were performed in Perkin Elmer 
Thermocycler 9600. The PCR products were visualized and documented as described 
previously for ITS region.  
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 Optimization of PCR protocols: 2.5 
2.6 
PCR protocols, applied with different primers were optimized mainly with regard to 
MgCl2 and primer concentration, amount of template DNA and cycling program for 
both direct and nested PCR. To detect DNA contamination from other samples a 
negative control (PCR mix plus water instead of DNA) were done.  For diagnostic 
purposes further additional negative control (PCR mix plus DNA from patients who 
had diseases other than VL) was performed for diagnostic purposes. These two 
negative controls were performed with each set of PCR amplification reaction. 
 
Single stranded conformation polymorphism (SSCP): 
SSCP is performed by denaturing the double -stranded DNA products as follows: 10 µl 
of each PCR product were added to 3 µl denaturing buffer (0.01 M EDTA, 1% SDS) 
and 2 µl loading buffer (80% Glycerine, 0.1 M EDTA pH 8, 10 mM Tris-HCl pH 8, 
0.1% Bromophenol blue). The mixture was heated to 98oC for 15 min and immediately 
chilled on ice and kept at 4oC for 15 min. These samples were loaded on acrylamide 
gel 350x450x0.8 mm [37.5 ml MDE-gels solution (FMC Bioproducts, Rockland, 
USA), 9 ml 10x TBE (10.8%Tris, 5.5% Boric, 0.02 M EDTA pH 8), 103.5 ml distilled 
water, 60 µl NNNN-Tetramethylene diamine (TEMED), 600 µl 10% APS 
(Ammonium peroxide sulphate)]. The samples were subjected to electrophoresis in 
0.5xTBE (0.023 M Tris-borate, 0.5 mM EDTA) which was run in a cold room (7-8oC) 
at 3 kV, 300 mV and amount of Watt and running time depending on the region under 
investigation (Table 2). Following electrophoresis, the gel was fixed in 1% Nitric acid 
for 15 min, subsequently the gel was washed in distilled water for 20 sec, then stained 
in 2% AgNo3 for 25 min. After washing for 10 min in distilled water, the gel was 
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 placed in freshly prepared developing solution (3% Sodium carbonate with addition of 
formaldehyde up to 0.05%).  
 
Table 2: Conditions for SSCP analysis of different PCR products 
DNA region Watt Running time (hr) 
ITS1 12 17 
ITS2 27 17 
ITS2 A 10 15 
ITS2 B 15 20 
Gp63-X 18 18 
Gp63-y 14 17 
Gp63-Z 25 17 
413 10 10 
114 10 10 
K413 10 10 
510 10 12 
308 10 10 
110 20 18 
 
 
 
 
PCR- fingerprinting: 2.7 
The PCR- fingerprinting technique was performed as described by Schönian et al. 
(1996). The following oligonucleotides which anneal to mini- and microsatellite DNA 
sequences were used as single primers in the PCR experiments: The core sequence of 
phage M13 (Huey and Hall, 1989) 5’- GAGGGTGGCGGTTCT-3’; the simple repeat 
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 sequence (GTG)5 5’-GTGGTGGTGGTGGTG-3’; and (GACA)4 5’-
GACAGACAGACAGACA-3’ (Ali et al., 1986) as well as the T3B oligonucleotide 5’-
AGGTCGCGGGTTCGAATCC-3’ which was derived from  an intergenic spacer of 
tRNa genes (McClelland et al., 1992). 
Table 3: PCR program for PCR-fingerprinting using the primers T3B, (GTG)5,   M13 core 
and (GACA)4.  *ID: Initial denaturation.  ** F: Final 
Primer  
PCR-program T3B (GTG)5 M13 core (GACA)4 
*ID 95oC  2min 95oC  2min 95oC  2min 95oC  2min 
Denaturation 
Annealing 
Extension 
No. of cycles 
95oC  20sec 
52 oC   30sec  
72oC  80sec 
32 
95oC  20sec 
50oC  30sec   
72oC  80sec 
32 
95oC  20sec 
50oC  60sec 
72oC  20sec 
27 
95oC  20sec 
50oC  60sec 
72oC  20sec 
35 
**F. extension 72oC  6min 72oC  6min 72oC  6min 72oC  6min 
 
Amplification reactions were performed in volumes of 50 µl containing 10 ng template 
DNA for the primers (GACA)4 and T3B, 50 ng for the primer (GTG)5 and 25 ng for 
the M13 core primer; 1x PCR buffer (10 mM Tris-HCl, pH 8.0; 50 mM KCl; 1.5 mM 
MgCl2); 3 mM Mg-acetate; 200 µM each of dNTPs (Pharmacia Biotech, USA) and 2.5 
U Taq polymerase (Perkin Elmer, Roche Molecular System, USA). The primers 
(GTG)5 and (GACA)4 were added to a final concentration of 5 pmol per 50 µl assay 
where as T3B and M13 core were added at final concentrations of 10 pmol and 25 
pmol, respectively. Samples were overlaid with sterile, light mineral oil (Stigma, 
Deisenhofen, Germany) and amplified in a Perkin-Elmer Thermocycler 9600 as shown 
in table (3). 
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 Samples were concentrated to a volume of approximately 20 µl using speed vacuum 
dryer (Speed Vac. Savant-Hicksville, NY, USA) and subjected to electrophoresis in 
1.2% agarose NA gel (Pharmacia Biotech AB, Uppsala, Sweden) for 5 hours at 100 
Volts in 0.5x TBE buffer (0.023 M Tris-borate, 0.5 mM EDTA). Amplification 
products were detected under UV light after staining the gel with Ethidium bromide 
(0.5 µg/ml) for 15 minutes. The gel was run once again for band sharpening at 125 
Volts for 15 min. Finger printing profiles were documented by photography (on 
Polaroid films, USA) or by a camera (Eagle Eye 11, Stratagene, Heidelberg). 
 
2.8 Restriction fragment length analysis (RFLA): 
The entire amplified ITS region, was digested using 10 different enzymes (Alu1, Bst 
U1, Cfo1, Dde1, EcoR1, Fsp1, Mse1, Msp1, Nde1 and Taq1) according to the 
conditions recommended by the supplier. Briefly, 17 µl of the DNA were restricted by 
addition of 10 units of each enzyme and 2 µl of the corresponding buffer and incubated 
at 37oC (with exception of Taq1 which is incubated at 65oC) for 2 hours. Restriction 
products plus 3 µl loading buffer (80% glycerine, 0.1 M EDTA pH 8.0, 10 mM Tris -
HCl pH 8.0) were subjected to electrophoresis in 1.3 % metaphore agarose (for fine 
analytical separation of small nucleic acids and PCR products, FMC Bio Products 
Rockland, ME, USA) for 2 hours at 80 Volts in 0.5 TBE buffer (0.023 M. Tris-borate, 
0.5 mM EDTA). DNA fragments were visualized under UV light after staining for 15 
min in ethidium bromide (0.5µg/ml). The gel was run again for 15 min at 100 Volts for 
increased resolution. Restriction products were documented by photography (on 
Polaroid films, USA) or by a camera (Gene Eagle Eye 11,Stratagene, Heidelberg). 
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 2.9 
2.9.1 
2.9.2 
Radioactive cycle sequencing:  
Template purification: 
The quality of the sequence data depends directly on the purity of DNA products. 
Hence prior to sequencing, 100 µl of the PCR products were purified by loading them 
on 1% agarose NA gel (Pharmacia Biotech AB, Uppsala, Sweden). Electrophoresis 
was performed in 0.5x TBE buffer (0.023 M Tris-borate, o.5 mM EDTA). Agarose 
blocks containing amplified DNA fragments were cut out from the gel under UV light 
using sterile scalpel and purified using QIA quick gel extraction kit (QIAGEN, Hilden, 
Germany) according to the instructions given by the manufacturer. 
 
Sequencing cycles: 
Sequencing was performed using ThermoSequenase radiolabeled terminator cycle 
sequencing kit (Amersham Life Science, Inc.26111 Miles Rd., Cleveland, OH44128 
USA) according to the instructions given by the supplier. Briefly, purified PCR 
products were amplified twice using the forward primer on the first amplification and 
the reverse primer on the second amplification. 7 µl purified DNA, 8 µl distilled water, 
2 µl Thermo SequenaseTM reaction buffer, 1 µl of 3 pmol solution single primer and 2 
µl Thermo SequenaseTM DNA polymerase were mixed together. The mixture was 
divided into four 0.5 ml microcentrifuge tubes, labelled A, C, G and T each one 
containing 4.5 µl reaction mix. To each tube the corresponding 2.5 µl radiolabeled 
termination reaction mix (0.5 µl of [α-33P] ddNTP, 2 µl dGTP) was added. Then each 
tube was overlaid with sterile light mineral oil (Sigma, Deisenhofen, Germany). 
Thereafter amplification reactions were performed in Biometra- Trio-Thermoblock as 
follows: initial denaturation at 95oC for 2 min, followed by 32 cycles consisting of 
44 
 denaturation at 95oC for 30 sec, annealing according to the primers (the same 
annealing temperature used for PCR amplification of the specific region), and 
extension at 72oC for 80 sec. After PCR cycle sequencing is completed 4µl from the 
stop buffer were added to each tube. The tubes were stored at -4oC until use for 
electrophoresis. 
 
 
 
2.9.3 Preparation of the sequencing plates and electrophoresis: 
Long run ranging sequencing gel glass plates (450x350mm) were cleaned twice with 
distilled water, and once with 70% ethanol. One of the glasses (earless glass) was 
wiped with acrylease (Stratagene, Heidelberg). Spacers (0.4 mm) were placed between 
the plates of both sides and the bottom side. The two glasses were fixed together using 
clips. 
 
Amplification products were subjected to electrophoresis. Polyacrylamide gel 
450x350x0.4mm (48% urea, 6% rotiphorese gel 40 [Fa. Roth, Karlsruhe], 15ml 20x 
Glycerol tolerant buffer, added to this 20 µl TEMED and 1 ml 10% APS) was poured 
into the prepared plates. Then a comb was inserted and the gel was allowed to 
polymerize at room temperature for 2 hours. Samples were preheated at 70oC for 10 
min before loading onto the gel to prevent formation of secondary structure. Three µl 
of each sample (labelled A, C, G and T respectively) were loaded on the gel. The 
samples were run in 1x Glycerol- tolerant gel buffer (21.6% Tris-hydroxymethyl-
aminomethane GR, 7.2% Taurine, 0.4% EDTA) at 1500 Volts for 3 hours (short run),  
for 6 hours (middle run) and at 1000 Volts for 13 hours (long run). Then the gel was 
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 fixed in 10% glacial acetic acid for 20 min, transferred to GB002 Gel blotting paper 
460x570mm, wrapped with Saran Wrap and dried in a Slab gel dryer (Savant-
Hicksville, N.Y., USA) at 80oC for 1.5 hour. After complete drying Saran Wrap was 
peeled off and the radiation was measured in impulses per second using a LB122 
Berthold β- δ detector. The dried gel was attached to X-ray hyperfilmTM MP 
(Amersham Buchler GmbH, Braunschweig, Germany) and kept in the dark room on 
carton file. After a time of exposure dependant on the amount of measured 
radioactivity (if less than 200 IPS, 10 days; greater than 200 IPS, 3 days; more than 
800 IPS one day), the autoradiograph was developed using (Hyperprocessor, 
Amersham). The sequence was read and interpreted in both directions using the 
computer program for sequencing (Esee, the eye ball sequence editor, version 1.09e). 
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3 Results 
3.1 Clinical manifestation: 
The disease in this study area was found to affect mainly children below 11 years of 
age and young adults between age 11 and 30 (Figure 5). There was male predominance 
(79%). Most of the patients (86%) were migrants of different tribes from western 
Sudan or Falata from Chad and Nigeria. There were also 5 patients from Eretria. The 
disease was found to affect mainly those of low socio-economic class (for details see 
appendix 1). 
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Figur. 5:  Age and sex distribution of kala-azar patient from eastern Sudan around El Gedaref 
between April 1997 and November 1998 
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 Direct detection of Leishmania parasites in clinical samples: 3.2 
3.2.1 
3.2.2 
3.2.3 
Microscopy: 
Overall from the 100 Giemsa-stained thin films, 71 samples were found to be 
microscopically positive. Twenty two of these were found to be negative when 
microscopic examination was performed on samples collected from lymph node 
aspirates. These samples were found to be positive when examination was carried out 
on samples collected from bone marrow aspirates and one sample from skin smear. 
 
PCR results: 
All the 71 selected microscopically positive clinical samples, which were collected 
from the field work were also positive in nested PCR when ITS1 and ITS2 regions 
were used as targets for amplification. In the first round of ITS-PCR these samples 
were also positive, but some showed weak PCR products. Fourteen of the 29 
microscopically negative clinical samples were found to be PCR positive, whereas the 
remaining 15 clinical samples were also PCR negative. All negative controls were 
negative; i.e. no contamination or inhibition was detected. 
 
Lymph node aspirates: microscopy versus PCR: 
Lymph node aspirates were subjected to microscopy and PCR (ITS1 and ITS2 regions). 
A comparison of the results is given in table (4). PCR detected significantly more 
Leishmania parasites than did microscopy (P<0.001), in the clinical samples collected 
from lymph node aspirates. Of the 36 lymph node samples with a positive PCR results 
but a negative microscopy result, 21 were from patients with confirmed visceral 
leishmaniasis (VL) on the basis of microscopy of bone marrow aspirates, 15 were from 
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 VL suspects (microscopically negative on basis of  bone marrow and   lymph node 
aspirates 
Table 4: Comparison of the results obtained by PCR and microscopy with clinical  samples  
collected from lymph node aspirates 
Microscopy  
Positive Negative 
Total 
Positive 49 36 85 PCR 
Negative       0 15 15 
 Total 49 51 100 
 
P < 0.001 
X2 =16.9555 
 
 but patients had clinical symptoms of leishmaniasis). Of the 15 samples, which were 
found to be negative by microscopy and PCR, one sample was collected from a lymph 
node of a post kala-azar dermal leishmaniasis patient (PKDL).  
 
Bone marrow aspirates: microscopy versus PCR: 3.2.4 
Bone marrow aspirates were subjected to microscopy and PCR (ITS1 and ITS2 
regions). A comparison of the results is given in table (5). PCR detected  significantly 
more Leishmania parasites than did microscopy (P<0.001), in the clinical samples 
collected from bone marrow aspirates. Of the 15 samples, which were found to be 
negative by microscopy and PCR one sample was collected from a bone marrow of a 
PKDL patient. 
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 Table. 5: Comparison of the results obtained by PCR and microscopy with clinical samples 
collected from bone marrow aspirates 
Microscopy  
Positive Negative 
Total 
Positive 21 15 36 PCR 
Negative       0 15 15 
 Total 21 30 51 
 
P < 0.001 
X2 = 14.875 
 
 
Detection of DNA polymorphisms in the ITS sequences: 3.3 
The ITS sequences were amplified from genomic DNA extracted  from the clinical 
samples  collected in Sudan  but   also from 18 cultured strains of L. donovani. 
 
Samples were scored as positive for the presence of Leishmania if a PCR product of 
approximately 1020 bp was obtained for the entire ITS region. When ITS1 and ITS2 
were amplified separately, amplification products of about 320 and 700 bp, 
respectively, were obtained. When ITS2A and B were amplified separately, PCR 
products of about 300 and 450bp, respectively, were observed (Figure 6). 
To test for sequence heterogeneity which could be detected by RFLP, the entire ITS 
region was cut with 10 different enzymes, the profiles of all 86 (71 microscopically 
confirmed cases plus the 15 Sudanese cultured samples) studied strains were, however 
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 indistinguishable. Figure (7) showed the restriction pattern obtained by Cfo1 as an 
example. 
 
 
Figure. 6:  PCR products amplified from 2 different clinical isolates of Leishmania. Lanes 
1&2: ITS PCR products (1020bp); Lanes 3&4: ITS1 PCR products (320bp); Lanes 5&6: ITS2 
PCR products (700bp); Lanes 7&8: ITS2A PCR products (300bp); Lanes 9&10: ITS2B PCR 
products (450bp); M: Molecular size (weight) standard marker; Kbp: Kilobase-pairs 
 
 
When ITS1 PCR products were subjected to SSCP, in total 14 ITS1 polymorphic 
profiles (Figures 8a & 8b; Appendix 2) could be distinguished among all 89 (71 
microscopically confirmed cases plus the 18 {15 from Sudan and 3 from other 
regions} cultured samples) tested isolates. Two of these patterns namely K and N were 
demonstrated by the samples of Kenya, India and China.  
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Figure 7: RFLP banding patterns obtained by digesting the amplified ITS regions of different 
clinical samples of L. donovani with  Cfo1 enzyme. M: molecular size (weight) standard 
marker; Kbp: Kilobase-pairs.  
 
The Kenyan and Indian samples had the same pattern K, whereas the Chinese isolate 
exhibited pattern N. The other 12 patterns were demonstrated by the samples from 
Sudan. The dominant pattern, A, was found in 66 of the 86 VL cases (76.7%) from 
Sudan, followed by pattern D, C and H, which were observed in 5, 4 and 3 cases, 
respectively i.e. (5.8%, 4.6% and 3.5%). Each of the other 8 patterns, namely J, E, L, B, 
F, G, I and M, were obtained from only one VL case each. 
In total 5 ITS2 polymorphic SSCP profiles could be distinguished among all 89 (71 
microscopically confirmed cases plus 18 cultured samples) tested isolates (Figure 9; 
appendix 2). Concerning the 86 Sudanese isolates, all of them had the same pattern A 
with exception of one sample, which had the pattern J. This sample had the pattern J in 
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 ITS1 SSCP analysis. Samples from Kenya, India and China had the patterns X, Y and 
Z, respectively. 
 
 
Figure 8a: SSCP analysis of ITS1 regions amplified from different clinical Leishmania 
donovani isolates. Each SSCP pattern is designated by a capital letter. Patterns A, C and D 
were very similar but the size of the upper fragment in pattern D was slightly larger than in 
pattern A. The upper fragment in pattern C had two very close bands. Lane 1: L. donovani 
MHOM/SD/62/LRC-L61 (positive control). Lane 2-12: strains of L. donovani from eastern 
Sudan. 
 
ITS-PCR products of Leishmania donovani samples representing different SSCP 
banding patterns were sequenced in both directions to determine the underlying 
nucleotide polymorphisms. 
The complete dominant ITS sequence (A) is shown in figure (10). The alignments of 
the variable parts of the ITS1 and ITS2 sequences, which showed variation from the 
dominant ITS sequence (A) are shown in figures (11&12), respectively. All the 
variations in the ITS1 SSCP banding patterns were due to deletion of AT pairs or 
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 adenine bases from stretches in the first part of the ITS1 (first 192 nucleotides) with 
exception of the Chinese isolate which has in addition 2 substitutions at positions 27 
and 89 (sequence LdN, Figure 11). In the patterns E, H and L sequences between the 
nucleotides 73 to 110 were not readable because different nucleotides were found in 
the same position (2 or 3 and sometimes all 4). These findings were confirmed by 
repeating sequencing using forward and reverse primers. 
 
Figure 8b: SSCP analysis of ITS1 regions amplifyed from different clinical Leishmania 
donovani isolates. Each SSCP pattern is designated by a capital letter. Lane 1: L. donovani 
MHOM/SD/62/LRC-L61 (positive control). Lanes 2&3: L. donovani strains from eastern 
Sudan; Lane 4: L.donovani MHOM/KE/85/NLB323 (Kenya); Lane 5: L.donovani 
MHOM/IN/71/LRC-L51a (India); Lane 6: l.donovani MHOM/CN/??/Wangjiel (China). 
 
No sequence variation was observed in the ITS2A region (positions 320-602) in all 
isolates. The Sudanese isolates had the same ITS2B sequence (positions 603-1042) 
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 with the exception of one sample, which had a deletion of one guanine base from a G 
stretch, at position 831 (LdJ sequence). 
 Isolates from Kenya and India (LdX and LdY sequences, respectively) differed in a 
single nucleotide, at position 762 in their ITS2B sequence, but showed many 
nucleotide differences when compared with the Sudanese isolates (Sequences, LdA, J 
and D) and to the Chinese isolate (sequence LdZ). 
 
Figure 9: SSCP analysis of ITS2 regions amplified from different clinical Leishmania 
donovani isolates. Each SSCP pattern is designated by a capital letter. Lane1: L.donovani 
MHOM/SD/62/LRC-L61 (positive control); Lanes 2&3: L.donovani strains from eastern 
Sudan; Lane 4: L.donovani MHOM/KE/85/NLB323 (Kenya); Lane 5: L.donovani 
MHOM/IN/71/LRC-L51a (India); Lane 6: l.donovani  MHOM/CN/??/Wangjiel (China). 
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3.4 Detection of DNA polymorphisms in the gp63 sequences: 
When part of the coding region of gp63 (XYZ) was amplified from leishmania clinical 
samples, PCR products of about 1350bp were obtained. When X, Y and Z were 
amplified separately, PCR products of about 400bp, 350bp and 600bp respectively, 
were obtained ( Figure 13; Appendix2). 
 
 
Figure 13: PCR products amplified from 3 different clinical isolates of Leishmania donovani. 
Lanes 1,2&3: XYZ gp63 PCR products (1350); Lanes 4,5&6: X gp63 PCR products (450bp); 
Lanes 7,8&9: Y gp63 PCR products (350bp); Lanes 10,11&12: Z gp63 products (600bp); M: 
Molecular size (weight) standard marker; Kbp: Kilobase-pairs. 
 
In total 31 clinical Leishmania samples spotted on filter papers were investigated. 
When X and Z regions were used as a target for SSCP analysis, no differences were 
observed, all the samples had the same SSCP profiles. When Y region was used as a 
target, 3 polymorphic patterns were observed (Figure 14; Appendix 2). The dominating 
pattern A was represented by 27 samples. The other patterns B and C were represented 
by 1 and 3 samples, respectively. 
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Figure 14:  SSCP analysis of Y regions of gp63 gene amplified from different clinical 
Leishmania donovani isolates from eastern Sudan. Each SSCP pattern is designated by a 
capital letter. Patterns A and B were very similar but the size of the upper fragment in pattern 
A was slightly larger than in pattern B.  Also the size of the lower fragment of pattern A is 
slightly smaller than in pattern B and there is very faint additional band. Lane 1: L. donovani 
MHOM/SD/62/LRC-L61 (positive control). The position of the bands are indicated by arrows. 
 
 
Nucleotide polymorphisms, obtained by sequencing of part (Y) of the coding region of 
gp63, and representing the 3 different SSCP banding patterns were due to single base 
exchanges (one transition and 2 transversions) as shown in figure (15). 
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 3.5 Detection of DNA polymorphisms in different 
anonymous DNA fragments: 
When anonymous DNA fragments, namely L0110, L510, L413, LK413, L0308 and 
L0114 were amplified from leishmanial genomic DNA, PCR products that were about 
580, 250, 300, 350,120 and 230 bp respectively, were obtained ( Figure 16). 
Unfortunately we succeeded to get good PCR products only for DNA extracted from 
the 8 successful cultures. Only for the fragment 110 we were able to get  good PCR 
products from 31 samples spotted on filter papers as well. For the other anonymous 
fragments only, weak, faint and sometimes no PCR products could be amplified 
directly from clinical samples spotted on filter papers. 
 
Figure 16: DNA fragments amplified from 2 different clinical isolates of Leishmania 
donovani. Lanes 1&2: PCR products obtained for anonymous fragment (110); Lanes 3&4: 
PCR products obtained for anonymous fragment (510); Lanes 5&6: PCR products obtained for 
anonymous fragment (413); Lanes 7&8: PCR products obtained for anonymous fragment 
(K413); Lanes 9&10: PCR products obtained for anonymous fragment (308); Lanes 11&12; 
61 
 PCR products obtained for anonymous fragment (114); M: Molecular size (weight) standard 
marker; Kbp: Kilobase-pair. 
SSCP was performed for the 6 anonymous DNA fragments namely, L0110, L510, 
L413, LK413, L0308 and L0114. Concerning the region L0110, 31 samples were 
investigated and no differences in SSCP patterns were observed. For the other 5 
fragments the 8 cultured samples were investigated and also no differences in SSCP 
patterns were observed with exception of 114 region, which showed two patterns. 
Pattern A was represented by 7 samples. The other pattern B was represented by one 
sample (Figure 17; Appendix 2). When SSCP was applied, for the anonymous DNA 
fragments obtained from faint PCR products amplified from samples spotted on filter 
papers, no reliable results were obtained. 
 
1 2 3 4 5 6 7 8 9 
A B A A A A A A A 
 
Figure 17: SSCP analysis of anonymous fragment (114) amplified from different clinical 
Leishmania donovani isolates from eastern Sudan. Each SSCP pattern is designated by a 
capital letter. Lane 1: L. donovani MHOM/SD/62/LRC-L61 (positive control). 
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 The sequences of the 6 amplified anonymous loci in the L.donovani DNA were shown 
in figure (18). Only locus 114 sequence showed 2 polymorphic patterns A&B which 
differed by one A/C exchange in position 127 and a small insertion/deletion in position 
111. 
 
PCR fingerprinting: 3.6 
PCR fingerprinting technique using M13 and T3B primers revealed no differences in 
profiles of all 26 studid L. donovani strains (8 successful cultures from eastern Sudan 
plus the 12 obtained from the collection of the Royal Tropical Institute, Amsterdam 
and the 6 WHO reference strains). 
  3.0
   2.0
   1.6
   1.0
   0.5
   0.4
  0.35
 
Figure 19: Results of the PCR fingerprinting using the (GTG)5 primer. Lane 1-3: Sudanese 
strains of L. donovani MHOM/SD/62/LRC-L61, MHOM/SD/98/GCI, and Don 13. Lane 4: 
L.donovani MHOM/KE/85/NLB323. Lane 5: L. donovani MHOM/IN/71/LRC-L51a. Lane6: 
L.donovani MHOM/CN/??/Wangjie1. M; molecular size (weight) standard marker. Kbp: 
Kilobase-pairs. 
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 PCR fingerprinting technique using M13 and T3B primers revealed no differences in 
profiles of all 26 studid L. donovani strains (8 successful cultures from eastern Sudan 
plus the 12 obtained from the collection of the Royal Tropical Institute, Amsterdam 
and the 6 WHO reference strains). 
 
When the (GTG)5  primer was used, L. donovani from India showed a unique profile 
(Fig.19, lane 5 ); the fingerprint of the Chinese strain (Fig.19, Lane 6) was very similar 
to those of the Sudanese strains; however, the high molecular weight bands appeared 
very faint, which might be due to partial degradation or  
 
Figure 20: Results of the PCR fingerprinting  using the (GACA)4 primer. Lane 1-3: Sudanese 
strains of L. donovani MHOM/SD/62/LRC-L61, MHOM/SD/98/GCI, and Don 13. Lane 4: 
L.donovani MHOM/KE/85/NLB323. Lane 5: L. donovani MHOM/IN/71/LRC-L51a. Lane6: 
L.donovani MHOM/CN/??/Wangjie1. M; molecular size (weight) standard marker. Kbp: 
Kilobase-pairs. 
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lower concentration of DNA in this sample. With the primer (GACA) 4 identical 
 fingerprinting patterns were obtained for all isolates from Sudan with the exception of 
the one ITS2 pattern J isolate (Fig. 20, Lane 3). This Isolate differed slightly from the 
other Sudanese isolates as did the isolate from China (Fig.20, Lane 6). The Kenyan and 
the Indian isolates (Fig.20, lanes 4&5, respectively) showed the same profiles with this 
primer.  
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 4 Discussion 
In this study we evaluated the use of nested PCR utilizing the ITS1 and ITS2 regions 
as targets for diagnosis and direct differentiation of Leishmania donovani. Also PCR 
products of gp63 and anonymous regions were attempted for the characterization and 
identification of intraspecific polymorphisms of the causative agent of visceral 
leishmaniasis (VL) in eastern Sudan from clinical samples spotted on filter papers 
using SSCP technique. Also we assessed DNA polymorphisms among 23 cultured L. 
donovani isolates from eastern Sudan, one from Kenya, one from India and one from 
China with 4 different PCR based approaches as tools to detect polymorphisms.  
 
The present study showed that PCR of both inguinal lymph node and bone marrow 
aspirates is significantly more positive than microscopy (tables 4 & 5). No difference 
was detected between microscopy and PCR when the clinical materials were taken 
from patients with confirmed cases of VL.This is in agreement with Osman et al. 
(1997). However, Leishmania DNA was demonstrated in 48.3% of VL suspect cases, 
thereby confirming the clinical diagnosis. This indicates that the main advantage of 
using PCR as a diagnostic tool is for VL suspects. 
 
The sensitivity of microscopic examination of smears from lymph node varies from 
78% (Siddig et al., 1989) to 58.3% (Zijlstra et al., 1992), while the sensitivities of 
microscopy of splenic and bone marrow aspirates were 96.4 and 70.2% (Zijlstra et al., 
1992). This is congruent with the findings of this study, where 30% of the clinical 
samples from lymph node aspirates that were found to be negative on basis of 
microscopy, were positive when the aspirates were taken from bone marrow. This 
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 observation indicates that the significance of microscopy results should be judged 
carefully against the types of the clinical material. 
 
 When 3 clinical samples were taken from lymph node, bone marrow and skin from 
post kala-azar dermal leishmaniasis (PKDL) patient and PCR was performed for these 
samples, a positive result was obtained only from the skin sample. Although one 
sample is not enough to draw a conclusion, the same result was obtained by Osman et 
al. (1998) who found that only 2 of 18 bone marrow aspirates from PKDL patients to 
be positive in PCR. This is probably due to the clearance of parasites from the lymph 
node and bone marrow as cell-mediated immunity develops during or after treatment 
of VL. 
 
PCR of the entire ITS region of L. donovani was found to be less sensitive than PCR of 
the 18S ribosomal RNA described by Osman et al., (1997 & 1998). In spite of this, 
ITS region is targeted in a nested PCR (ITS1 & ITS2) because sequences of this region 
are more variable and allow clear species identification by RFLP or SSCP and also 
strain differences could be expected. 
 
Various DNA techniques have been valuable for the study of genetic variation, and 
their application has provided a wealth of molecular data (McManus & Bowles, 1996). 
Intraspecific variation in SSCP banding patterns was clearly observed in the ITS1 
region with 12 profiles detected among Sudan isolates, with profile A being dominant 
(76.7%), and 2 ITS1 –SSCP profiles observed among the samples from Kenya, India 
and China. On the other hand, all but one of the Sudanese samples had the same ITS2 
– SSCP pattern (A). Isolates of the same species (L. donovani) but of different 
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 geographical origin had showed varying ITS2-SSCP patterns. We may conclude that 
ITS2-SSCP pattern analysis could be a useful method for differentiation of L. donovani 
strains from different geographical areas. To consolidate this observation, more 
samples from different geographical origins are required.  
 
 Iwahana et al. (1992) claim that PCR-SSCP analysis is only effective for DNA 
fragments of less than 300 to 400 bp. Therefore the ITS2 region was further divided 
into 2 regions (ITS 2A and ITS 2B), using internal primers. Again the same above 
result was obtained. This means that ITS2 sequence seems to be highly conserved in 
all investigated L. donovani isolates from Sudan, with the exception of only one 
sample. In contrast, ITS1 region appears to undergo more rapid evolutionary changes 
and may vary among populations of the same species of the same geographical origin. 
The polymorphisms in the ITS1 observed in this study were independent of the clinical 
symptoms, of the stage of the disease and of the tribe of the patient.  
 
DNA fragments showing different SSCP patterns were further characterized by 
radioactive cycle sequencing to determine the underlying nucleotide polymorphisms. 
Different patterns in the ITS1 region were mainly due to deletion of Adenine residues 
from A stretches or AT pairs (Fig.11). This may be attributed to the weak AT double 
bond. Patterns L, H and E have a unique part in their sequences where different 
nucleotides were located at the same position. This is already clearly indicated in the 
SSCP analysis where patterns L and H consist of multiple bands (Fig.8a). This may be 
attributed to the fact that the ITS region is a multi-copy gene and heterogeneity may 
also arise between individual copies of the ribosomal operon, but mixed infections or 
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 hybrids by different strains of L. donovani can not be excluded. The results obtained 
by SSCP for ITS2 were also confirmed by DNA sequencing. 
 
Intraspecies variations in SSCP banding patterns were clearly observed in the coding 
region of gp63 with 3 profiles detected among 31 Sudanese L. donovani isolates. These 
results were also confirmed by DNA sequencing. The gp63 molecule participates in 
the parasites initial attachment to mammalian macrophages and likely contributes to 
their survival within the macrophage phagolysosomes (Bordier, 1987; Chang et al., 
1990). This finding indicates that gp63 could be a potential useful marker for study of 
polymorphisms. Those polymorphisms can possibly correlated to the severity of the 
disease The same result was obtained by Victoir et al. (1998) who illustrates the very 
high genomic and genetic plasticity of gp63 genes revealed by gp63-RFLP and PCR-
RFLP in 4 species of subgenus viannia and the possibility to relate these genetic 
differences to phenotypic properties, such as pathogenicity. 
 
Six amplified  anonymous regions of DNA were screened for polymorphisms with the 
SSCP technique from isolates spotted on filter papers. Unfortunately good SSCP 
results were obtained from only one region. In contrast to this finding, good PCR 
products and SSCP polymorphic patterns were observed among cultured Sudanese L. 
donovani (DON12- DON23) using the same anonymous primers (Lewin, 2000). This 
difference  may be due to the fact that, these anonymous regions represent single copy 
genes and hence the SSCP was hampered by the little amount of PCR products 
obtained from samples spotted on filter papers. At the same time good results were 
obtained when SSCP was performed for 8 of the same above isolates but from cultured 
parasites. We may conclude that anonymous regions could be good for population 
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 genetics studies taking into consideration, they are single copy genes and thus, can 
address for genetic diploidy and sexual reproduction of Leishmania provided that there 
is large amount of PCR products. 
 
No intra-specific variation was observed in the RFLP patterns when the amplified ITS 
regions of different strains of L donovani, were digested with a panel of different 
frequently cutting restriction enzymes (Fig. 7). This may be explained by the fact that 
sequence variation may go undetected by RFLP analysis since the restriction enzymes 
survey only a subset of the total variable sites (Stothard et al., 1997). 
 
In contrast to this observation, considerable heterogeneity was found within the ITS-
RFLP of strains of L. tropica and L. aethiopica (Schönian et al., 2000 & 2001) and of 
New World species of Leishmania whereas different species showed different levels of 
variation (Guevara et al. 1992; Cupolillo, et al. 1995). These findings reveal that 
different levels of heterogeneity occur within different species of Leishmania. 
 
When PCR-fingerprinting approach was done on cultured parasites, highly similar 
PCR profiles were observed between all tested isolates (Figs. 19&20); thus confirming 
previous results (Schönian et al., 1996; Oskam et al., 1998; Lewin, 2000). This may be 
attributed to the fact that the fingerprinting technique is less discriminatory because 
mutations can be detected only if they affect primer-binding sites or if they lead to 
bigger insertions/deletions that would change the fragment size. Gasser (1997) also 
reported that fragments of the same size but differing in sequence will co-migrate 
within one band in a gel, and may be misinterpreted as the same sequence. 
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 We can conclude that SSCP is advantageous relative to both PCR-RFLP and PCR-
fingerprinting approaches for the detection of sequence variation in rRNA genes within 
the L. donovani species. The SSCP technique is sensitive to detect genetic diversity 
that differed by only one nucleotide (Fig. 12 sequences, LdX & LdY).  
 
In addition, ITS-SSCP is a technique that can be performed easily and rapidly, directly 
from blotted clinical samples infected with Leishmania parasites without prior 
cultivation of the parasite, unlike PCR-fingerprinting. Samples collected under field 
conditions where cultures are vulnerable to contamination can be analysed directly by 
PCR-SSCP methods in specialized laboratories. Further more, by cultivating the 
leishmania parasite it is possible that mixed infections will be missed due to different 
growth rates of different strains in blood agar culture (Ibrahim et al., 1994). Thus 
SSCP can be an excellent method for the screening of genetic polymorphisms within 
the genus Leishmania because it can be used with low parasite numbers and 
contaminated samples. Samples showing different SSCP patterns could be 
subsequently sequenced. Automated direct sequencing of the PCR product without 
prior screening by the SSCP technique might be profitable for the detection of 
polymorphic sequences in single copy genes. However with multicopy genes, SSCP is 
of advantage because direct sequencing is hampered by possible sequence differences 
among the individual copies (see patterns E, H, and L in this study). 
 
 In this study, of 40 cultures attempts in the field only 8 were successful. This was due 
to problems with contamination (aseptic techniques in the field were not ideal as in the 
equipped laboratory), problems with the conservation of adequate media, and problems 
with maintenance of the optimal temperature under field conditions. Simultaneously, 
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 we were able to apply ITS-SSCP for these 8 samples directly from collections obtained 
by spotting of the lymph node or bone marrow aspirates on filter papers. Although 
SSCP has been used to detect sequence variation in ITS, gp63 and anonymous regions 
of L. donovani, this method could be a powerful analytical tool also for other parasitic 
organisms. SSCP can also be used for the detection of strain-specific polymorphisms 
not only in the above mentioned targets but also in any already published sequence and 
thus lessen the dependence on reference laboratories for identification of Leishmania 
strains. 
 
No correlation was however discerned between the PCR-SSCP polymorphic patterns 
and the clinical manifestation of the human disease (6PKDL, 83 VL and 1 CL patients). 
Also Schönian et al., (2000, 2001) found no correlation between different ITS-RFLP, 
fingerprinting patterns and the clinical manifestation of the disease caused by the L. 
aethiopica and also the disease caused by L. tropica. It would be interesting to 
determine whether L. donovani causing mucosal leishmaniasis, PKDL and VL in 
Sudan could be correlated with specific SSCP patterns, may be other gene (i.e. virulent 
genes that still have to be identified) could be used as a target in further study. 
 
There was male predominance among the patients in this study area. This may be due 
to the male greater outdoor exposure to sandfly and the greater value placed on male 
lives, which bring them in close contact with the forest. The high infection rate among 
children may indicate that some infections are domestic or peridomestic. Most of the 
patients in this area were from low socio-economic class, anaemic and this may 
indicate that leishmaniasis has characteristics of an opportunistic disease too. 
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 Lastly we can emphasise that, it is a high time in Sudan to find a quick accurate tool 
for differential diagnosis between endemic diseases resembling clinically 
Leishmaniaasis, like chronic malaria, typhoid, brucellosis, trypanosomiasis. PCR 
diagnosis evaluated in this study can be used as a supplement to the existing gold 
standard microscopic method, especially for leishmaniasis suspect cases. This will help 
in prescribing accurate treatment, improving quality of the care of the patient and 
reduce the morbidity and mortality rates. Also it can be applied to samples collected 
from vector or reservoir host to support control program. 
 
The advantage of the PCR products investigated in this study is that can be used for 
epidemiological, population genetics studies and for typing of the organism. Because 
this method is expensive to be done as a routine work in Sudan, it can be 
recommended for diagnosis of unusual clinical presentation as a second line 
confirmation in an algorithm of diagnosis. 
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 4.1 Conclusions: 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
PCR is especially useful for the confirmation of cases suspected of VL. Also PCR can be 
performed successfully, directly from clinical samples spotted on filter papers with no 
prior cultivation. 
Nested ITS- PCR is a more sensitive method than microscopy for the detection of 
leishmania parasites. In addition ITS sequences are variable and hence allow strain 
differences. 
SSCP has the advantage over both RFLP and PCR fingerprinting that it can detect DNA 
polymorphisms and point mutations at a variety of positions in DNA fragments. Also it has 
higher resolution power for strain identification, which is required for understanding of the 
epidemiology of leishmania. 
Anonymous regions, which are single copy genes, could be good markers especially for 
population genetics studies provided that we have large amount of PCR products. 
Gp63 could be a potential useful marker for study of polymorphisms and the possible 
correlation of these polymorphisms to the severity of the disease. 
Different levels of heterogeneity occur among different species of Leishmania with L. 
tropica being most variable (Schönian et al.; 2001) followed by L. aethiopica (Schönian et 
al., 2000) and then L. donovani (this study, Lewin, 2000) 
It would be interesting to determine whether L. donovani causing mucosal leishmaniasis, 
VL and PKDL in Sudan could be correlated with specific SSCP patterns, may be other 
relevant genes could be used in further study using SSCP technique. 
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 Appendices 4.3 
Appendix 1: Demographic and clinical data for112 visceral leishmaniasis patients 
from eastern part of Sudan around Gedaref State (April 1997-November 1998). 
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1152 
1150 
1129 
18C 
39 
1110 
1117 
36 
31 
30 
29 
M 
F 
M 
M 
M 
M 
M 
M 
M 
M 
F 
M 
F 
F 
M 
M 
M 
F 
M 
M 
M 
M 
9 
7 
12 
25 
10 
39 
13 
17 
20 
18 
9 
11 
12 
11 
20 
17 
10 
7 
18 
14 
4 
18 
LN, BM 
LN, BM 
LN 
LN, BM 
LN 
LN, BM 
LN 
LN, BM 
LN, BM 
LN, BM 
LN, BM 
LN, BM 
LN, BM 
LN, BM 
LN, BM 
LN, BM 
LN, BM 
LN, BM 
LN 
LN 
LN 
LN 
VL 
N.N 
VL 
N. N 
VL 
VL 
VL 
N. N 
VL 
N. N 
VL 
N .N 
VL 
VL 
N. N 
VL 
N.N 
VL 
VL 
VL 
VL 
VL 
W. Sudan 
E. Sudan 
W.  Sudan 
Falata 
Eretria 
Falata 
Falata 
Falata 
Arab 
W. Sudan 
Falata 
Falata 
Falata 
Falata 
W.  Sudan 
Arab 
W. Sudan 
W. Sudan 
W. Sudan 
W.  Sudan 
W. Sudan 
Falata 
 
 23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
28 
26 
22 
19 
16 
15 
13 
12 
11 
10 
9 
8 
7 
3 
2 
19C 
13C 
9C 
60 
103 
100 
76 
71 
61 
102 
70 
M 
M 
M 
M 
F 
M 
M 
M 
M 
F 
F 
F 
M 
M 
F 
M 
F 
M 
M 
M 
M 
M 
M 
M 
M 
M 
28 
23 
19 
11 
13 
20 
6 
27 
8 
11 
6 
5 
18 
21 
13 
24 
18 
11 
7 
18 
4 
17 
14 
14 
23 
35 
LN, BM 
LN 
LN 
LN, BM 
LN 
LN 
LN, BM 
LN 
LN, BM 
LN 
LN 
LN, BM 
LN 
LN 
LN, BM 
LN, BM 
LN 
LN 
LN, BM 
LN 
LN 
LN 
LN 
LN 
LN 
LN 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
Falata 
W. Sudan 
W. Sudan 
Falata 
W. Sudan 
Falata 
Falata 
W. Sudan 
W. Sudan 
W. Sudan 
W. Sudan 
W. Sudan 
Falata 
W. Sudan 
Falata 
Eretria 
W. Sudan 
Eretria 
Falata 
W. Sudan 
W. Sudan 
W. Sudan 
W. Sudan 
Falata 
Falata 
S. Sudan 
49 
50 
51 
52 
90 
101 
18 
104 
M 
M 
M 
M 
25 
25 
22 
22 
LN, BM 
LN, BM 
LN, BM 
LN 
VL 
VL 
VL 
VL 
C. Sudan 
W. Sudan 
W. Sudan 
Eretria 
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 53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
82 
4 
1 
5 
1140 
1135 
72 
1116 
6 
42 
40 
13N 
46 
3N 
2N 
1149 
24 
14 
25 
15C 
21 
1147 
35 
5C 
16C 
79 
4C 
27 
8C 
3C 
7C 
M 
M 
F 
F 
M 
M 
M 
M 
M 
F 
M 
M 
M 
M 
F 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
F 
F 
M 
M 
12 
21 
9 
8 
29 
16 
4 
13 
17 
12 
28 
7 
1 
5 
12 
13 
35 
9 
2 
8 
9 
14 
18 
24 
24 
18 
12 
12 
18 
10 
LN 
LN 
LN 
LN 
LN, BM 
LN 
LN 
LN, BM 
LN 
LN, BM 
LN 
LN 
LN, BM 
LN, BM 
LN 
LN 
SKIN, LN, BM 
LN 
LN 
LN 
LN 
LN, BM 
LN 
LN, BM 
LN, BM 
LN, BM 
LN, BM 
LN, BM 
LN, BM 
LN, BM 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
N. N 
N. N 
VL 
VL 
PKDL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
Falata 
W. Sudan 
W. Sudan 
W. Sudan 
W. Sudan 
W. Sudan 
Falata 
W. Sudan 
W. Sudan 
Falata 
W. Sudan 
W. Sudan 
W. Sudan 
W. Sudan 
Falata 
W. Sudan 
W. Sudan 
W. Sudan 
W. Sudan 
W. Sudan 
Falata 
Falata 
Arab 
W. Sudan 
W. Sudan 
Arab 
W. Sudan 
W. Sudan 
Falata 
W. Sudan 
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 83 
84 
85 
86 
87 
88 
89 
90 
91 
92 
93 
94 
95 
96 
20C 
2C 
10C 
66 
86 
67 
C 
E 
B 
A 
D 
62 
75 
63 
M 
F 
F 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
M 
15 
20 
7 
14 
17 
13 
20 
13 
14 
30 
25 
20 
17 
31 
LN, BM 
LN, BM 
LN, BM 
LN 
LN, BM 
LN 
LN 
LN 
LN, BM 
LN 
LN 
LN 
LN, BM 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
VL 
N. N 
W. Sudan 
Falata 
W. Sudan 
W. Sudan 
Arab 
Arab 
W. Sudan 
Falata 
Falata 
Falata 
W. Sudan 
W. Sudan 
W. Sudan 
Eretria 
97 
98 
99 
100 
101 
102 
103 
104 
105 
106 
107 
108 
109 
110 
111 
112 
81 
97 
10N 
11N 
DON12 
DON13 
DON14 
DON15 
DON16 
DON17 
DON18 
DON19 
DON20 
DON2I 
DON22 
DON23 
M 
F 
M 
F 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
9 
13 
20 
16 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
LN, BM 
LN, BM 
LN, BM 
LN, BM 
BM 
BM 
BM 
BM 
BM 
BM 
LN 
BM 
BM 
BM 
BM 
LN 
N. N 
N. N 
N. N 
N. N 
VL 
VL/PKDL 
VL 
VL 
VL 
VL 
PKDL 
PKDL 
VL 
VL 
PKDL 
PKDL 
Falata 
W. Sudan 
Falata 
W. Sudan 
N. N 
N. N 
N. N 
N. N 
N. N 
N. N 
N. N 
N. N 
N. N 
N. N 
N. N 
N. N 
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Samples from 101 to 112 were obtained from the collection of the Royal Tropical Institute, Amsterdam. 
*  M: male; F: female. **  LN: lymph  node; BM: bone marrow 
***  VL: visceral leishmaniasis, PKDL: post kala-azar dermal leishmaniasis 
***  VL/PKDL: simultaneous VL and  PKDL, N.N:  not known 
****  W: western, E:  eastern, C: central, S: southern 
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Appendix 2: Strains of Leishmania donovani analysed in this study and the results of analyses. 
 
Serial 
number 
Identification number SSCP ITS1 
pattern 
SSCP ITS2 
pattern 
SSCP gp63 
(Y) pattern 
SSCP 114 
marker 
pattern 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
2C 
20C 
3C 
15C 
8C 
4C 
16C 
5C 
DON 12 
DON 13 
DON 14 
DON15 
DON 16 
DON 17 
DON 18 
DON 19 
DON 20 
DON 21 
DON 22 
DON 23 
MHOM/SD/75/LV139 
MHOM/SD/62/LRC-L61 
MHOM/SD/68/1S 
A 
A 
A 
A 
A 
A 
A 
A 
A 
J 
D 
A 
A 
D 
D 
A 
A 
A 
A 
D 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
J 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
C 
A 
A 
C 
A 
A 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
A 
n.d. 
A 
B 
A 
A 
A 
A 
A 
A 
n.d 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
A 
n.d. 
A 
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 24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
 
MHOM/KE/85/NLB323 
MHOM/IN/71/LRC-
L51a 
MHOM/CN/??/Wangjiel 
10C 
25 
1140 
1147 
24 
1135 
104 
70 
4 
1149 
3 
79 
35 
27 
21 
40 
1 
7C 
5 
42 
1116 
14 
 
K 
K 
N 
A 
C 
C 
D 
A 
A 
A 
M 
C 
C 
A 
A 
B 
A 
A 
A 
A 
A 
A 
A 
A 
A 
 
 
X 
Y 
Z 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
n.d. 
n.d. 
n.d. 
A  
A  
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
B 
A 
A 
A 
A 
C 
A 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
49 
50 
51 
72 
102 
97 
A 
A 
A 
A 
A 
A 
A 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
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 52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
66 
67 
68 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
D 
46N 
103 
44 
10N 
100 
11N 
32 
75 
36 
62 
9C 
16 
E 
12 
15 
10 
9 
7 
C 
B 
13N 
26 
!7 
86 
A 
66 
67 
76 
71 
H 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
E 
A 
A 
A 
L 
H 
H 
A 
F 
G 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
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 82 
83 
84 
85 
86 
87 
88 
89 
 
61 
30 
31 
29 
18 
22 
13C 
39 
I 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
 
 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
n.d. 
      
      
      
 
 
n.d.: not done 
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